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Hydration	   in	   the	   minor	   groove	   of	   B-­‐form	   DNA	   influences	   the	   stability	   and	  
conformation	  of	  duplex	  DNA.	  An	  analogue	  nucleoside	   that	  attempts	   to	  mimic	   the	  N3-­‐
hydrated	  adenine	  was	  designed	  and	  synthesized.	  Obtaining	  the	  modified	  adenine	  was	  a	  
signifcant	  synthetic	  effort.	  The	  attempted	  incorporation	  of	  the	  new	  analogue	  in	  a	  DNA	  
strand	  yielded	  inconclusive	  results,	  and	  further	  tests	  are	  ongoing.	  The	  incorporation	  of	  
the	  new	  modified	  purine	  in	  a	  DNA	  duplex	  may	  be	  useful	  for	  a	  better	  understanding	  of	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1.1.	  The	  Roles	  of	  Nucleic	  Acids	  
Deoxyribonucleic	  acid	  (DNA)	  and	  ribonucleic	  acid	  (RNA)	  are	  essential	  to	  the	  central	  
dogma	  of	  molecular	  biology	  introduced	  by	  Francis	  Crick.1	  It	  describes	  how	  information	  is	  
transferred	   and	   stored	   in	   living	   organisms.2	   The	   study	   of	   the	   information	   carriers	   –	  
nucleic	  acids	  –	  has	  become	  a	  journey	  consisting	  of	  combined	  efforts	  of	  many	  scientists	  
and	  ultimately	  changed	  the	  way	  we	  live.	  	  
From	  the	  discovery3-­‐5	  of	  helical	  structure	  of	  DNA	  to	  the	  human	  genome	  sequencing	  
project,	   the	   path	   has	   been	   very	   controversial	   and	   many	   ethical	   questions	   about	   the	  
consequences	  of	   the	   findings	  have	  been	  raised.	  DNA	  technology	  not	  only	   transformed	  
the	   understanding	   of	   diseases	   and	   treatments,	   but	   also	   crossed	   the	   boundaries	   of	  
science	  and	  medicine	  affecting	  all	  areas	  of	  our	  life.	  Changes	  in	  the	  world	  of	  legal	  matters	  
and	   forensic	   science6	   have	   come	  as	   an	   immediate	   application	  of	   the	  new	  discoveries.	  
Scientists	   are	   constantly	   searching	   for	   new	   ways	   of	   making	   sequencing	   cheaper	   and	  
faster.	  Next-­‐generation	  sequencing	  platforms	  have	  emerged	  and	  enabled	  a	  wide	  variety	  
of	   applications,	   “allowing	   researchers	   to	   ask	   virtually	   any	   question	   of	   the	   genome,	  
transcriptome,	  and	  epigenome	  of	  any	  organism.”7	  We	  are	   looking	  at	  the	  future	  where	  
the	  sequencing	  of	  a	  patient’s	  genome	  in	  a	  doctor’s	  office,	  “while-­‐you-­‐are-­‐waiting”,	  is	  a	  
routine	   procedure.	   Possible	   uses	   of	   this	   sensitive	   information	   raise	   the	   concerns	   of	  
privacy	  and	  moral.	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In	   addition	   to	   such	   important	  practical	   applications	  of	  DNA	   technology	  as	   the	  one	  
towards	  the	  diagnosis	  of	  diseases	  and	  production	  of	  new	  pharmaceuticals,	  agricultural,	  
environmental,	   and	   engineering	   opportunities	   are	   hard	   to	   overestimate.	   The	   DNA	  
duplex	   structure	   has	   a	   great	   potential	   in	   the	   construction	   of	   nanodevices.8	   The	   self-­‐
assembly	   and	   sequence	   specific	   recognition	   of	   DNA	   can	   lead	   to	  miniature	   electronics	  
and	  optical	   devices,	   biosensors	   and	  probes.	  Genetic	   advances	   in	   agriculture	   increased	  
the	  production	  of	   food	  and	  helped	   in	   the	   fight	  against	  hunger	  on	   the	  planet	  with	   the	  
population	   of	   seven	   billion	   people.	   Yet	   the	   long-­‐term	   effects	   of	   genetically	   modified	  
produce	   are	   unclear.	   Some	   of	   the	   risks	   amount	   to	   “potential	   human	   health	   impacts,	  
including	  allergens,	  transfer	  of	  antibiotic	  resistance	  markers,	  and	  unknown	  effects.”9	  
Another	   reason	   to	   study	   DNA	   is	   to	   understand	   evolution.	   Analysis	   of	   a	   genetic	  
sequence	   has	   become	   a	   much	   more	   powerful	   method	   than	   examination	   of	   physical	  
traits.10-­‐12	   It	   turns	  out	   that	  millions	  and	  millions	  of	  species	  on	  the	  Earth	  are	  all	   related	  
and	  are	  made	  from	  the	  same	  four	  building	  blocks	  of	  DNA.	  
The	   understanding	   of	   DNA	   and	   RNA	   three-­‐dimensional	   structures	   has	   advanced	  
dramatically	   since	   their	   initial	  discovery.13,14	  This	  progress	  has	  been	   largely	  due	   to	   the	  
increased	   power	   and	   resolution	   capabilities	   of	   X-­‐ray	   crystallography.15	   But	   more	  
recently	  other	  important	  methods	  have	  emerged	  and	  play	  important	  roles	  in	  providing	  
structural	   information:	   NMR	   spectroscopy,16	   molecular	   modeling,	   and	  
chemical/biochemical	  probe	  techniques.17	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2.2.	  Structural	  Features	  of	  Nucleic	  Acids	  
A	  detailed	  description	  of	  structural	  parameters	  in	  nucleic	  acids	  can	  be	  found	  in	  many	  
sources;14,18,19	   here,	   only	   the	   elements	   that	   are	   essential	   to	   the	   title	   project	   are	  
considered.	   Fundamentally,	   the	   four	   nucleosidic	   bases	   in	   DNA	   and	   RNA	   that	   are	  
responsible	   for	   coding	   the	   genetic	   information	   are	   adenine,	   cytosine,	   guanine,	   and	  
thymine	  for	  DNA	  (Figure	  1A)	  and	  adenine,	  cytosine,	  guanine,	  and	  uracil	  for	  RNA	  (Figure	  
1B).	  	  
The	  sugar-­‐phosphate	  backbone	  bridges	  the	  nucleosides	  creating	  a	  long	  polymer	  that	  
finds	  another,	   complementary	   strand	   to	  pair	  with.	  The	   right-­‐handed	  duplex	  of	  natural	  
DNA	   forms	   due	   to	   hydrogen	   bonding	   between	   the	   nucleobases,	   modulation	   of	  
electrostatic	   repulsion	  by	  cations,	  and	  hydrophobic	  static	   interactions	  being	   the	  major	  
factors.	  The	  asymmetry	  in	  base	  pairs	  results	  in	  two	  parallel	  types	  of	  grooves:	  major	  and	  
minor	  (Figure	  2).	  
DNA	   has	   an	   overall	   negative	   charge	   due	   to	   the	   phosphodiesters	   in	   the	   backbone.	  
Phosphoric	  acid	  is	  unique2	  due	  to	  several	  important	  factors.	  Specifically,	  it	  can	  “link	  the	  
two	  nucleotides	  and	  still	  ionize,”	  stabilizing	  the	  diesters	  against	  hydrolysis	  and	  retaining	  
the	   DNA	   molecule	   within	   a	   lipid	   membrane.	   The	   negative	   charge	   metal	   ions	   that	  




Figure	  1.	  The	  Nucleosidic	  Bases	  in	  DNA	  (A)	  and	  RNA	  (B)	  
	  
In	  spite	  of	  its	  high	  level	  of	  stability,	  DNA	  is	  still	  fairly	  flexible.	  The	  duplex	  can	  attain	  
several	   conformations	   –	   a	   phenomenon	   termed	   polymorphism.	   The	   most	   common	  
forms	   are	   the	   A-­‐form	   and	   B-­‐form	   DNA,	   with	   the	   B-­‐form	   the	   most	   common	   at	  
physiological	  conditions.	  	  
The	  favored	  structure	  of	  a	  duplex	  is	  determined	  by	  many	  forces.	  DNA	  duplexes	  are	  
not	  static	  structures;	  they	  are	  equilibrium	  states	  of	  dynamic	  structures.	  DNA	  can	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Figure	  2.	  DNA	  duplex	  shown	  in	  ball-­‐and-­‐stick	  and	  space	  filling	  representations.	  Images	  
adapted	  from	  Sanger14.	  
	  
compress,	   stretch,	   bend	   under	   the	   influence	   of	   many	   factors:	   DNA	   sequence,	   salt	  
content,	   metal	   ion	   binding,	   temperature,	   protein	   interactions,	   and	   hydration.	   Base-­‐
complementarity	  is	  one	  of	  the	  most	  important	  factors	  for	  the	  formation	  and	  stability	  of	  
the	  duplex.	  Base-­‐stacking	  or	  pi-­‐stacking	  is	  an	  important	  stabilizing	  factor	  when	  p-­‐orbitals	  
of	   the	   aromatic	   rings	   of	   the	   heterocycles	   interact.	   Since	   DNA	   has	   an	   overall	   negative	  
charge,	  the	  repulsion	  of	  the	  phosphate	  groups	  can	  be	  mitigated	  by	  binding	  cations.	  This	  




Since	   structure	   dictates	   function,	   the	   overall	   shape	   of	   a	   duplex	   directs	   its	  
interactions	  with	  proteins	  and	  growth	  factors.	  In	  general,	  the	  major	  groove	  of	  B-­‐DNA	  is	  
more	  accessible	  and	  binds	  a	  wider	  range	  of	  molecules	  compared	  to	  the	  minor	  groove.	  
The	  major	  and	  minor	  grooves	  differ	  in	  functional	  groups,	  electrostatic	  potential,	  sterics,	  
and	   hydration.	   The	   minor	   groove	   binding	   ligands	   often	   contain	   aromatic	   rings	   that	  
become	   isohelical	   with	   the	   groove	   (repeating	   the	   curve	   of	   the	   helix),	   for	   example,	  
netropsin,	  distamycin,	  berenil.14b	  
DNA	  structure	  and	  conformation	  is	  highly	  dependent	  on	  the	  sequence.	  A-­‐DNA	  is	  rich	  
in	   G-­‐C	   base	   pairs	   (Figure	   3);	   A-­‐T	   rich	   sequences	   demonstrate	   B-­‐DNA	   parameters.	   If	   a	  
DNA	  duplex	  has	  a	  run	  of	  several	  consecutive	  A-­‐T	  base	  pairs,	  called	  A-­‐tracts,21	  the	  minor	  
groove	   becomes	   unusually	   narrow,	   creating	   a	   special	   electrostatic	   binding	   pocket	   for	  
positively	  charged	  ligands.	  Several	  crystallographic	  studies	  have	  reported	  that	  the	  width	  
of	  the	  minor	  groove	   in	  A-­‐T	  regions	   is	  about	  2.8-­‐3.2	  Å	  compared	  to	  6.0	  Å	   in	  average	  B-­‐	  
DNA.	  Since	  the	  DNA	  minor	  groove	   is	  narrower	   in	  A-­‐T	  rich	  sequences,	  aromatic	  rings	   in	  
the	  minor	  groove	  binding	   ligands	   fit	   better	   and	  make	  optimal	   van	  der	  Waals	   contacts	  
with	   the	   walls	   of	   the	   groove.	   Additional	   specificity	   is	   guaranteed	   by	   the	   functional	  





Figure	  3.	  The	  Watson-­‐Crick	  base	  pairs	  
In	  a	  G-­‐C	  base	  pair,	  the	  amino	  group	  of	  guanine	  presents	  a	  steric	  block	  for	  the	  binding	  of	  
small	  molecules.	  An	  adenine	  modification	  synthesized	  in	  this	  project	  continues	  the	  study	  




Modified	  nucleosides	  and	  nucleotides	  are	  found	  in	  nature	  and	  can	  also	  be	  obtained	  
synthetically.	  	  While	  biological	  molecules	  participate	  in	  regulation,	  defense,	  information	  
transfer,2,14	  etc.	   in	  organisms,	  synthetic	  nucleosides,	   in	  addition	  to	  medicinal	  purposes,	  
are	  widely	  used	  as	  probes22	  to	  study	  biological	  mechanisms.	  
Modified	   bases	   occur	   naturally	   mostly	   in	   transfer	   RNAs	   (tRNAs).	   The	   numerous	  
modifications23	   are	   involved	   in	   diversifying	   the	   genetic	   code,	   synthetase	   recognition,	  
and	   structure	   stabilization.	   A	   simple	   example	   of	   a	   modification	   is	   DNA	   methylation.	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Natural	  DNA	  contains	  5-­‐methylcytosine,	  N6-­‐methyladenine,	  and	  others.	  There	  are	  many	  
biological	  functions	  of	  methylation	  including	  gene	  expression,	  the	  discrimination	  of	  self-­‐
DNA	  from	  foreign-­‐DNA,	  and	  base-­‐base	  mismatch	  repair.	  	  
There	  are	  many	  applications	  of	  nucleobase	  modifications	  in	  research	  and	  medicine.	  
A	  duplex	   containing	  5-­‐propynyl-­‐dU	   is	   relatively	  more	   stable	  because	   stacking	  with	   the	  
neighboring	  bases	  is	  improved	  due	  to	  an	  extended	  π-­‐structure	  (Figure	  4).24,14b	  A	  greater	  
understanding	   of	   protein	   and	   drug	   binding	   in	   the	   Hoogsteen	   face	   of	   guanine	   has	  
improved	   by	   the	   synthesis	   and	   analysis	   of	   a	   7-­‐deaza-­‐dG	   residue	   and	   testing	   it	   in	   a	  
duplex.	  2-­‐Aminopurine	  is	  a	  fluorescent	  base	  and	  can	  be	  used	  as	  a	  probe	  of	  nucleic	  acid	  
conformations.	   5-­‐Bromo-­‐dU	   and	   5-­‐iodo-­‐dU	   undergo	   photolytic	   cross-­‐linking	   and	   are	  
used	  to	  cross-­‐link	  DNA	  and	  proteins.	  
	  Backbone	   and	   sugar	  modifications	   have	  been	   important	   in	   antisense	   therapies	  which	  
involve	   steric	   blocking	   or	   degradation	   of	   the	   coding	   strand	   of	   RNA	   through	   the	  
formation	  of	  a	  base	  paired	  duplex	  and	  subsequent	  inhibition	  of	  the	  gene	  expression.	  A	  
lot	  of	  anti-­‐viral	  and	  anti-­‐HIV	  compounds	  are	  chain	  terminators	  where	  the	  3’-­‐OH	  group	  is	  
absent	  so	  that	  phosphorylation	  cannot	  take	  place.	  Some	  examples25	  of	  these	  biologically	  
active	  modified	  nucleosides	  are	  zidovudine,	  zalcitabine,	  and	  abacavir.	  Other	  nucleoside	  
modifications	  (2’-­‐modifications26,	  PNA27,	  LNA28,	  phosphorothioates,29	  etc.)	  have	  become	  




	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  4.	  Nucleoside	  analogues	  used	  in	  structural	  studies	  
3-­‐Deazapurine	   are	   the	   analogues	   used	   in	   this	   project.	   The	   molecules	   with	   the	  
modification	   occur	   in	   nature	   and	   have	   antiviral	   and	   antibiotic	   activity.30	   In	   the	   lab,	   3-­‐
deazapurines	   have	   been	   used	   as	   various	   biological	   probes.	   For	   example,	   3-­‐deaza-­‐3-­‐	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	  5.	  Anti-­‐fixed	  purine	  analogue,	  3-­‐deaza-­‐3-­‐m3thyladenosine	  
methyladenosine	  (Figure	  5)	  has	  been	  used	  as	  an	  anti-­‐fixed	  purine	  analogue,31	  and	  as	  an	  
analogue	  of	  N3	  methylated	  adenosine,	  a	  cytotoxic	  lesion	  in	  DNA.32	  This	  project	  explores	  
the	   synthesis	   of	   a	   new	   3-­‐deaza-­‐3-­‐substituted	   adenine	   and	   its	   ability	   to	   probe	   the	  





1.3.	  Steps	  in	  Chemical	  Synthesis	  of	  Nucleosides	  and	  DNA,	  and	  	  	  	  	  	  	  	  	  	  
the	  Use	  of	  Tetramethylsuccinimide	  Protecting	  Group	  in	  
Glycosylation	  
Chemical	  synthesis	  of	  DNA33-­‐36	  is	  usually	  done	  automatically	  using	  phosphoramidite	  
chemistry	  on	  a	  solid	  support	  (Figure	  6).	  The	  resulting	  single-­‐stranded	  chain	  consists	  of	  a	  
number	   of	   building	   blocks—nucleosides—connected	   with	   a	   phosphodiester	   bridge14	  
(see	   section	   1.2).	   Many	   types	   of	   nucleosides,	   both	   natural	   and	   unnatural,	   are	  
commercially	   available	   and	   are	   ready	   to	   be	   incorporated	   into	   oligonucleotides.	   The	  
challenge	  of	  this	  project,	  as	  well	  as	  several	  other	  projects	  in	  the	  McLaughlin	  group,	  was	  
to	   synthesize	   and	   use	   novel	   modified	   nucleosides.	   The	   new	   modifications	   can	   be	  
designed	  so	  that	  the	  DNA	  duplexes	  have	  new	  and	  useful	  properties.	  
There	  are	  several	  prevalent	  strategies14,37	   in	  the	  synthesis	  of	  modified	  nucleosides.	  
The	  glycosydic	  bond	  can	  be	  created	  by	  a	  nucleophilic	  attack	  on	  the	  sugar	  by	  a	  nitrogen	  
or	  a	  carbon	  atom	  of	  a	  modified	  nucleobase.	  Alternatively,	  the	  base	  can	  be	  constructed	  
starting	  at	  the	  prebuilt	  nitrogen	  or	  carbon	  on	  the	  sugar.	  When	  the	  former	  method	  A	  is	  
chosen	   (as	   it	  was	   in	   this	   project,	   see	   Chapter	   2)	   three	  major	   stages	   of	   synthesis	   take	  
place.	  First,	  the	  required	  modification	  is	  installed	  on	  the	  nucleobase,	  then	  the	  glycosydic	  




Figure	  6.	  Steps	  in	  solid	  phase	  DNA	  phosphoramidite	  synthesis	  cycle36.	  
Formation	   of	   the	   glycosydic	   bond	   presents	   a	   number	   of	   challenges.	   Natural	  
nucleosides	  have	  a	  β-­‐configuration	  at	  C1	  carbon,	  and	  in	  most	  of	  the	  synthetic	  methods	  
at	   least	  some	  of	  the	  unwanted	  α-­‐isomer	  is	  formed.	  On	  the	  other	  hand	  nitrogen	  atoms	  
on	  the	  heterocyclic	  bases	  are	  similarly	  nucleophilic,	  which	  means	  that	  glycosylation	  can	  
take	  place	  at	  both	  N9	  and	  N7	  atoms	  (in	  purines).	  Obtaining	  the	  desired	  nucleoside	  with	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high	   regio-­‐	   and	   stereoselectivity,	   and	   in	   good	   yields	   became	   the	   goal	   of	   many	  
researchers	  including	  those	  in	  McLaughlin	  group.	  
Scheme	   1	   illustrates	   how	   in	   a	   purine	   glycosylation	   four	   different	   products	   can	   be	  









Scheme	  1.	  Possible	  products	  in	  the	  glycosylation	  using	  sodium	  salt	  method14	  
	  
In	  addition	  to	  the	  negative	  effects	  of	   the	   formation	  of	  multiple	   isomers	  on	  the	  overall	  
yields,	  the	  difficulty	  of	  glycosylation	  is	  emphasized	  at	  the	  chromatographic	  stage	  as	  the	  
products	  are	  very	  hard	  to	  separate.	  
One	  of	  the	  most	  used	  methods	  in	  the	  glycosylation	  of	  purines	  and	  deazpurines	  is	  the	  
sodium	  salt	  method.38	   In	   this	  method,	   the	  nucleobase	  anion	   is	   formed	   in	   the	   reaction	  
with	  sodium	  hydride	  (or	  potassium	  hydride)	  in	  acetonitrile.	  The	  resulting	  salt	  reacts	  with	  
chlorosugar	   (2-­‐deoxy-­‐3,5-­‐di-­‐O-­‐(4-­‐toluoyl)-­‐D-­‐ribofuranosyl	   chloride)	   via	   an	  SN2	   reaction.	  
The	   major	   product	   is	   the	   desired	   β-­‐2’-­‐deoxyribonucleoside	   with	   the	   correct	  
13	  
	  
configuration	  and	   regioselectivity.	   The	  high	  yield	   is	   the	   consequence	  of	   a	  much	   faster	  
nucleophilic	   attack	   of	   the	   purinyl	   anion	   and	   subsequent	   displacement	   of	   chloride	   in	  
comparison	  with	  the	  anomerization	  of	  the	  chlorosugar.	   	  The	  small	  amount	  of	  oxonium	  
ion	   that	   does	   form	   presents	   an	   opportunity	   for	   nucleophilic	   attack	   from	   above	   and	  
below	  the	  plane	  of	  the	  sugar	  which	  leads	  to	  the	  formation	  of	  the	  unwanted	  α-­‐isomer.	  
The	  glycosylation	  of	  nucleoside	  analogue	  1	  (Scheme	  1)	  proceeds	  with	  the	  formation	  
of	   the	   desired	   β-­‐N9	   isomer	   as	   the	   major	   product	   due	   to	   favorable	   electronics	   and	  
sterics.	   In	   the	   case	   of	   3-­‐deaza-­‐3-­‐substituted	   purines,	   such	   as	   7	   (Scheme	   2),	   the	  
electronics	  and	  sterics	  are	  not	  favorable	  for	  providing	  the	  correct	  selectivity.	  A	  series	  of	  
attempts	   were	   undertaken	   in	   the	   McLaughlin	   lab	   in	   order	   to	   synthesize	   3-­‐deaza-­‐3-­‐
substituted	   purine	   nucleosides39	   (Scheme	   2).	   Amination	   of	   8	   proved	   to	   be	   a	   more	  
difficult	   task	   in	   comparison	  with	  ordinary	   nucleosides.	  Usually,	   heating	  with	   ammonia	  
installs	   the	   amino	   group	   at	   the	   6	   position,	   simultaneously	   removing	   Tol	   protecting	  
groups.	   For	   3-­‐deaza-­‐3-­‐substituted	   purine	   nucleosides,	   the	   conditions	   must	   be	   much	  
harsher:	  an	  overnight	  treatment	  with	  hydrazine	  followed	  by	  a	  6	  h	  reaction	  with	  Raney	  
nickel.31	  
	  




In	   the	  McLaughlin	   lab,	   the	   improvements	   to	   the	   Irani	  procedure31	  were	  made	  and	  
resulted	   in	   higher	   yields	   of	   the	   N9	   product.	   Alternate	   coupling	   conditions	   were	  
examined,	  as	  well	   as	  modifications	   to	  7.	   The	  amine	  was	   installed	  before	   coupling	  and	  
protected	  in	  order	  to	  make	  the	  6	  position	  more	  bulky.	  A	  directing/protecting	  group	  with	  




Scheme	  3.	  The	  synthesis	  of	  2,2,3,3-­‐tetramethylsuccinic	  anhydride	  
The	   synthesis41	  of	   the	  M4SI	   group	   is	   shown	   in	  Scheme	  3.	   The	   starting	  material	   for	  
this	  procedure	  is	  AIBN	  10,	  a	  reagent	  commonly	  used	  as	  a	  radical	  initiator.	  Slow	  addition	  
of	  AIBN	  to	  hot	  heptane	  affords	  dinitrile	  11,	  which	   is	   suspended	   in	  aqueous	  H2SO4	  and	  
heated	  for	  two	  hours	  to	  obtain	  tetramethylsuccinic	  anhydride	  M4SA	  12.	  This	  compound	  
is	  not	  available	  commercially,	  but	  its	  preparation	  is	  a	  relatively	  easy	  procedure	  because	  
the	  crude	  product	  does	  not	  require	  chromatography	  and	  can	  be	  used	   immediately	   for	  
the	  next	  step.	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M4SA	   reacts	  with	   adenine	   and	  other	   purines	   (including	   deaza-­‐purines)	   in	   refluxing	  
pyridine	  in	  the	  presence	  of	  DBU	  (Scheme	  4).	  A	  small	  amount	  of	  the	  resulting	  amide	  can	  
be	  converted	  to	  the	  imide	  with	  refluxing	  SOCl2	  in	  78-­‐81%	  yields	  of	  the	  M4SI-­‐protected	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Scheme	  4.	  Installing	  the	  M4SI	  protecting	  group41	  
purine.	  The	  crystal	   structure	  of	  M4SI-­‐protected	  adenine	  shows	   that	   the	  methyl	  groups	  
are	   positioned	   above	   N7	   of	   adenine	   and	   block	   the	   access	   of	   this	   position	   for	   the	  
chlorosugar.	  	  
M4SI	  performed	  well	  with	  3-­‐deaza-­‐3-­‐substitued	  purines,	  which	  is	  why	  this	  protecting	  
group	  was	   chosen	   for	   this	  project.	   The	  M4SI	  protecting	  group	   is	   compatible	  with	  DNA	  
solid-­‐phase	   synthetic	   procedures	   and	   can	   be	   cleanly	   removed	   with	   ammonium	  
hydroxide	   at	   55⁰C.	   An	   important	   drawback	   is	   that	   a	   substrate	   like	   3-­‐deaza-­‐3-­‐
methyladenine	   protected	   with	   M4SI	   is	   a	   more	   hindered	   nucleophile,	   therefore	   the	  
reaction	   is	   slower	   and	   larger	   amounts	   of	   α-­‐nucleosides	   are	   formed.	   In	   spite	   of	   this	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disadvantage,	  M4SI	  successfully	  fulfills	  the	  roles	  of	  a	  directing/protecting	  group	  in	  case	  
of	  3-­‐deaza-­‐3-­‐substituted	  purines	  allowing	  for	  the	  synthesis	  of	  β-­‐purines	  in	  good	  yields.	  
	  
	  
1.4.	  Hydration	  as	  a	  Structural	  Feature	  of	  B-­‐DNA	  
Water	   is	  not	   just	  a	  medium	  to	  keep	  the	  solutes	  dissolved.	   It	   is	  also	  responsible	  for	  
stabilization	   of	   overall	   structure.	   In	   nucleic	   acids,	   phosphate—phosphate	   electrostatic	  
repulsion	   is	   diminished	   due	   to	   high	   dielectric	   constant	   of	  water.	   	   Bases	   self-­‐assemble	  
into	   ordered	   structures	   at	   least	   partially	   due	   to	   hydrophobic	   forces,	   and	   as	   a	  
consequence	  of	  entropy	  reduction	  driven	  by	  water	  molecules.	  	  
Many	  studies,18,	   42-­‐44	   including	  X-­‐ray	  crystallography,	  NMR,	  and	   IR	  have	  shown	  that	  
DNA	  duplex	  is	  hydrated,	  and	  that	  the	  hydration	  is	  not	  uniform	  around	  the	  molecule.	  The	  
distribution	  of	  water	  molecules	  depends	  on	   the	  helical	   type	  and	   the	  characteristics	  of	  
the	  grooves.15b	  
	  The	   hydration	   level	   can	   greatly	   influence	   a	   nucleic	   acid’s	   conformation.45	   In	   an	  
environment	  with	   relatively	   high	   humidity,	   DNA	   prefers	   to	   be	   in	   B	   form;	   A-­‐type	   DNA	  
occurs	   under	   conditions	   of	   low	   humidity	   or	   high	   salt	   concentration.	   As	   studies	   on	  
Dickerson-­‐Drew	   dodecamer	   have	   shown,14,18	   water	   molecules	   are	   found	   around	   the	  
phosphates,	   and	   around	   nitrogen	   and	   oxygen	   atoms	   in	   the	  major	   groove.	   The	  minor	  
groove	   contains	   two	   shells	   of	   hexagonally	   arranged	   water	   molecules	   that	   directly	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contact	  the	  bases.	  The	  zigzag	  pattern	  is	  named	  the	  spine	  of	  hydration	  and	  is	  considered	  
to	  be	  a	  strong	  stabilizing	  structural	  component	  of	  B-­‐DNA	  (Figure	  7).	  	  
The	  spine	  of	  hydration	  is	  a	  characteristic	  found	  in	  sequences	  rich	  in	  dA-­‐dT	  base	  pairs.	  
A	  molecule	  of	  water	  bridges	   the	  N3	  atom	  of	  adenine	  and	  O2	  carbonyl	  of	   the	   thymine	  
residue	   directly	   below.	   A-­‐DNA	   has	   the	   grooves	   of	   completely	   different	   size	   and	  
electronic	   characteristics,	   thus,	   does	   not	   have	   the	   same	   hydration	   pattern.	   A-­‐DNA	  
typically	  consists	  of	  long	  runs	  of	  C-­‐G	  base	  pairs.	  The	  amino	  group	  of	  guanine	  is	  bulky	  and	  
interferes	  with	  the	  formation	  of	  the	  “regular”	  spine	  of	  the	  molecules.	  
The	  spine	  of	  hydration	  in	  A-­‐T	  rich	  sequences	  stabilizes	  the	  B	  conformation.	  For	  this	  
reason	  complex	  poly(dA)*poly(dT)	  does	  not	  undergo	  transformation	  	  from	  B	  to	  A	  form.	  
Polynucleotides	   with	   guanosine	   replaced	   by	   inosine	   (lacking	   the	   N2	   amino	   group)	  
behave	   as	  A-­‐T	  polymers	   and	  occur	   in	  B-­‐family	   double	  helices.	   Theoretical	   calculations	  
suggested	   that	   the	   presence	   of	   the	   cross-­‐strand	   hydrogen	   bonding	   may	   stabilize	   the	  
duplex	  by	  inhibiting	  base	  pair	  opening.	  Another	  study	  suggested	  that	  the	  propeller	  twist	  
of	   the	   bases	   was	   sub-­‐optimal	   to	   accommodate	   the	   spine	   of	   hydration,	   which	  
compensated	  for	  the	  lost	  energy.46	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Figure	  7.	  Drawing	  shows	  schematically	  how	  water	  molecules	  are	  accommodated	  in	  the	  
minor	  groove	  of	  sequence	  AATT	  of	  the	  B-­‐DNA-­‐type	  dodecamer.	  The	  first	  hydration	  layer	  
is	  hydrogen	  bonded	  with	  pyrimidine	  O2	  and	  purine	  N3.Image	  adapted	  from	  Sanger.14	  
	  
In	   addition	   to	   the	   highly	   ordered	   hydration,	   duplexes	   containing	   long	   runs	   of	   A-­‐T	  
base	  pairs	  have	  another	   interesting	   feature:	   the	   formation	  of	   so-­‐called	  A-­‐tracts.47	   In	  a	  
recent	   review,21e	   Haran	   and	   Mohanty	   investigate	   the	   biological	   importance	   of	   these	  
repeated	   runs	   of	   4-­‐6	   adenine-­‐thymine	  base	  pairs	   that	   create	   “global	   curvature	   of	   the	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DNA	  duplex,	  which	  can	  be	  macroscopically	  characterized	  by	  anomalously	  slow	  migration	  
on	  polyacrylamide	  gels”.21e	  DNA	  A-­‐tracts	   are	  defined	  as	   four	  or	  more	   consecutive	  A-­‐T	  
base	  pairs	  without	  a	  T-­‐A	  step.	  Repeats	  of	  A4T4	  are	  bent,	  whereas	  T4A4	  are	  straight,	  the	  
fact	  that	  became	  the	  topic	  of	  study	  for	  many	  researchers.	  	  
It	   has	   been	   established	   from	  many	   oligonucleotide	   crystal	   structures	   that	   A-­‐T-­‐rich	  
minor	  grooves	  tend	  to	  be	  narrower	  than	  average.	  It	  has	  been	  observed49	  that	  the	  width	  
of	   the	   minor	   groove	   determines	   the	   hydration	   pattern.	   Privé50	   correlated	   the	   high	  
content	  of	  A-­‐T	  base	  pairs	  with	  a	  narrow	  minor	  groove	  and	  the	  resistance	  of	  A-­‐T-­‐rich	  DNA	  
to	  undergo	   the	   transition	   from	  B	   to	  A-­‐type,	   and	   concluded	   that	   the	   spine	  brought	   an	  
additional	  stabilization	  due	  to	  the	  greater	  isolation	  of	  the	  spine	  from	  the	  bulk	  solvent.	  
The	   exact	   role	   of	   hydration	   of	   DNA	   on	   its	   stability,	   geometry,	   ligand	   binding,	  
packaging	  of	  DNA	  is	  yet	  to	  be	  understood.	  Stability	  of	  duplex	  DNA	  and	  rules	  that	  change	  
it	   are	   central	   for	   understanding	   the	   many	   processes	   involving	   DNA.	   Although	   the	  
existence	  of	   the	   spine	  of	  hydration	  has	  been	  proven	  by	  X-­‐ray	   crystallography,14,48	   this	  
project	  probes	  the	  stability	  of	  the	  duplex	  DNA	  indirectly.	  	  
	  
	  
1.5.	  Previous	  Studies	  of	  the	  Hydration	  in	  DNA	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Most	  biological	  processes	  rely	  on	  molecular	  recognition	  and	  reversible	  interactions.	  
The	   structure	   of	   the	  DNA	   duplex	   and,	   consequently,	   replication	   and	   gene	   expression,	  
depend	  on	  interaction	  with	  proteins	  as	  well	  as	  ions	  and	  water.	  Water	  molecules	  can	  act	  
as	   both	   acceptors	   and	   donors	   of	   hydrogen	   bonds	   creating	   extended	   networks.	   The	  
hydration	  of	  DNA	  is	  essential	  for	  the	  maintenance	  of	  its	  structural	  integrity.	  
The	  role	  of	  “structural”	  waters	   in	   the	  major	  groove	  of	  DNA	  has	  been	  examined	  by	  
Richard	  Gumport.51	  His	   team	  synthesized	  a	  nucleoside	  analogue	  depicted	  on	  Figure	  8.	  
The	   structure	   was	   characterized	   by	   X-­‐ray	   diffraction	   and	   proton	   NMR.	   The	   crystal	  
structure	  shows	  an	   intramolecular	  hydrogen	  bond	  between	  an	  amino	  proton	  on	  N6	  of	  
adenine	   and	   the	   oxygen	   of	   the	   hydroxymethyl	   group.	   When	   superimposed	   onto	  
particular	  adenines	  in	  the	  structure	  of	  the	  tryptophan	  (trp)	  repressor/operator	  complex,	  
the	  analogue	  places	   the	  oxygen	  of	   the	  hydroxymethyl	   group	  very	   close	   to	   the	  oxygen	  
contributed	  by	  the	  water	  in	  the	  complex.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  8.	  Water	  mimic	  by	  Gumport51	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Eliminating	   interactions	   in	   the	   minor	   groove	   that	   are	   involved	   in	   the	   spine	   of	  
hydration	  allows	  measuring	  its	  contribution	  to	  the	  stability	  of	  duplex.	  With	  this	  in	  mind,	  
Richard	   Cosstick53	   and	   co-­‐workers	   prepared	   2'-­‐deoxy-­‐3-­‐deazaadenosine	   (dc3A)	   18,	  
Figure	   9.	   The	   incorporation	   of	   the	   analogue	   into	   a	   duplex	   DNA	   destabilized	   the	  
structure.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  9.	  2'-­‐deoxy-­‐3-­‐deazaadenosine	  (d3cA)53	  
Understanding	   the	   contribution	   of	   the	   hydration	   to	   duplex	   conformation	   and	  
stability	  has	  been	  one	  of	  the	  subjects	  of	  studies	  in	  the	  McLaughlin	  lab.	  The	  next	  chapter	  
discusses	   the	   results	   of	   the	   series	   of	   experiments	   including	   the	   findings	   of	   this	   thesis	  









The	  McLaughlin	  group	  has	  a	  long-­‐standing	  interest	  in	  studying	  the	  hydration	  of	  the	  
minor	   groove.	   In	   order	   to	   probe	   the	   spine	   of	   hydration,	   two	   analogue	   bases	  1	   and	  2	  
were	  synthesized54	   (Figure	  1).	  3-­‐Deazaadenine	  1	   is	  a	  derivative	  of	  adenine	  from	  which	  
N3	  has	  been	  deleted	  and	  3-­‐methyl-­‐2-­‐pyridone	  2	   is	  a	  C-­‐nucleoside	  that	  mimics	  thymine	  
but	  lacks	  the	  O2	  carbonyl.	  This	  base	  pair	  is	  similar	  to	  dA-­‐dT	  but	  eliminates	  the	  polar	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Figure	  1.	  T.	  Lan	  analogues.54	  
functional	   groups	   in	   the	   minor	   groove.	   Ultraviolet	   melting	   temperature	   studies	  
indicated	   that	   the	   presence	   of	   this	   base	   pair	   in	   dA-­‐dT	   rich	   sequence	   results	   in	   a	  
destabilized	   duplex.	  Moreover,	   circular	   dichroism	   studies	   have	   shown	   that	   sequences	  
with	   four	  analogue	  base	  pairs	  structurally	   resemble	  A-­‐form	  helices	   rather	   than	  B-­‐form	  
helices.	  On	  the	  contrary,	  when	  a	  single	  substitution	  is	  made	  in	  G-­‐C	  rich	  sequences,	  the	  
duplex	  stability	  is	  retained.	  This	  proves	  that	  the	  spine	  of	  hydration	  is	  disrupted	  while	  the	  
incorporated	  analogues	  do	  not	  affect	  the	  fundamental	  duplex	  properties	  of	  base	  pairing	  




Figure	  2.	  The	  modification	  of	  adenine	  3-­‐deaza-­‐3-­‐methyladenine	  (m3c3A)	  and	  3-­‐deaza-­‐3-­‐
hydroxymethyladenine	   (h3m3c3A)	   adds	   bulk	   into	   the	   minor	   groove.	   4	   increases	   the	  
stability	  of	  a	  duplex	  compared	  to	  3.	  
	  
In	  order	  to	  better	  understand	  the	  contribution	  of	  water	  molecules	  on	  the	  stability	  of	  B-­‐
form	   DNA,	   analogues	   3,	   3-­‐deaza-­‐3-­‐methyladenine,	   and	   4,	   3-­‐deaza-­‐3-­‐
hydroxymethyladenine	   were	   designed,	   synthesized55	   (Figures	   2	   and	   3),	   and	  
incorporated	  into	  a	  DNA	  duplex.	  Both	  of	  these	  modified	  nucleobases	  are	  “missing”	  the	  
N3	  nitrogen	  and,	  in	  addition,	  introduce	  steric	  bulk	  into	  the	  minor	  groove.	  	  
Three	  types	  of	  oligonucleotides	  were	  prepared:	  1)	  those	  containing	  3-­‐deazaadenine	  
1,	   2)	   those	   containing	  3-­‐deaza-­‐3-­‐methyladenine	  3,	   and	  3)	   those	   containing	  3-­‐deaza-­‐3-­‐
hydroxymethyladenine	  4.	  Thermodynamic	  parameters	  were	  obtained	  for	  the	  formation	  





	  	   	  
Figure	  3.	  (a)	  Water	  molecule	  hydrogen-­‐bonded	  to	  the	  N3	  of	  dA	  as	  part	  of	  the	  minor-­‐
groove	  spine	  of	  hydration;	  (b)	  Covalently	  bound	  water	  mimic55	  
	  
	  (duplex	   2)	   resulted	   in	   a	   2.4⁰C	   decrease	   in	   the	   melting	   temperature	   (TM).	   The	  
introduction	  of	  four	  deazaadenine	  residues	  (duplex	  5)	  reduced	  the	  TM	  by	  12.3⁰C.	  The	  3-­‐
deaza-­‐3-­‐methyl	   analogues	   destabilized	   the	   duplex	   (duplexes	   3	   and	   6,	   Table	   1)	   to	   a	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greater	   extent	   due	   to	   the	   increased	   steric	   bulk	   in	   the	   minor	   groove.	   Although	   the	  
hydroxymethyl	   group	   is	   even	   bulkier,	   its	   incorporation	   in	   a	   duplex	   (duplex	   4	   and	   7)	  
increased	  the	  TM	  relative	  to	  the	  methyl	  analogue.	  
	  
Table	  1.	  Thermodynamic	  stabilities	  of	  serlf-­‐complementary	  duplexes55	  
	  
These	   results	   show	   that	   the	   absence	   of	   hydrogen-­‐bonding	   acceptors	   in	   the	  minor	  
groove	  destabilize	  the	  duplex	  as	  a	  result	  of	  disruption	  of	  the	  spine	  of	  hydration.	  Methyl	  
groups	   also	   disrupt	   the	   spine	   of	   hydration,	   and	   introduce	   additional	   steric	   bulk.	  
Hydroxymethyl	   substituents,	   although	   the	   bulkiest,	   provide	   stabilization	   through	   a	  
modified	  water	  structure.	  A	  possible	  interaction	  mimicking	  water	  molecule	  is	  illustrated	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Figure	  4.	  (a)	  Representation	  of	  water	  molecules	  in	  the	  minor	  groove.	  Long	  ovals	  denote	  
adenine,	  short	  ovals	  denote	  thymine.	  The	  N3	  nitrogen	  of	  adenine	  and	  O2	  of	  thymine	  are	  
shown.	  (b)	  Structural	  water	  mimic	  provided	  by	  3-­‐deaza-­‐3-­‐hydroxymethyladenine.	  
	  
Although	  substitution	  of	  dA	  with	  hydroxymethyl	  analogue	  4	  relatively	  stabilizes	  the	  
duplex	  in	  comparison	  to	  3,	  the	  TM	  (duplex	  7,	  Table	  1)	  is	  still	  significantly	  lower	  than	  that	  
of	   the	   native	   sequence	   (duplex	   1).	   This	   thesis	   presents	   the	   synthesis	   of	   another	  
analogue	  of	  adenine	  5	  (Figure	  4)	  that	  may	  become	  a	  better	  mimic	  of	  water	  in	  the	  minor	  
groove.	   The	   hydroxyl	   group	   is	   positioned	   on	   an	   extended	   linker	   and	   may	   be	   more	  
effective	  in	  hydrogen	  bonding	  in	  the	  minor	  groove	  of	  B-­‐form	  DNA.	  
	  
Building	  on	  the	  work	  done	  by	  J.	  Arico55	  and	  T.	  Lan,54	  this	  project	  becomes	  a	   logical	  
extension	   of	   the	   previous	   research	   and	   investigates	   the	   synthesis	   of	   a	   novel	   adenine	  




	  	  	  	  	  	  	  	  	   	  
Fugure	  5.	  Adenine	  and	  its	  modifications.	  Nucleobase	  5	   is	  the	  target	  analogue	  that	  may	  
stabilize	   a	   B-­‐form	   DNA	   duplex	   via	   water	   mimic	   in	   the	   minor	   groove.	   Note,	   that	  
alternatively	  these	  analogues	  may	  be	  named	  using	  standard	  IUPAC	  nomenclature	  as	  the	  
imidazo[4,5-­‐c]pyridine	  ring	  system.	  
	  
The	   idea	   behind	   the	   design	   of	   (2-­‐(((4-­‐amino-­‐1H-­‐imidazo[4,5-­‐c]pyridin-­‐7-­‐
yl)methyl)thio)ethanol)	   5	   is	   that	   the	   molecule	   may	   increase	   the	   stability	   of	   the	   DNA	  
duplex	  compared	  with	  a	  duplex	  containing	  4.	  The	  thioethanol	  linker	  would	  provide	  extra	  
length,	  postulated	  to	  result	  in	  a	  better	  hydrogen	  bonding	  to	  the	  neighboring	  T.	  
The	   synthesis	   of	   the	   new	   nucleobase	   5	   builds	   on	   previous31,40,55	   	   synthetic	  
procedure.	   The	   first	   part	   of	   the	   synthesis	   (Scheme	  1)	   consists	   of	   a	   series	   of	   reactions	  
that	  results	  in	  3-­‐deazaadenine	  functionalized	  with	  the	  bromide	  group	  at	  the	  3	  position	  
(compound	  13).	  The	  original	  synthesis	  was	  proposed	  by	  Irani,31	  but	  later	  was	  improved	  
by	  Arico40,55	  in	  the	  McLaughlin	  group.	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Scheme	  1.	  Synthesis	  of	  3-­‐deaza-­‐3-­‐methyladenine	  
Refluxing	  commercially	  available	  3-­‐picoline-­‐N-­‐oxide	  6	   in	  a	  mixture	  of	   concentrated	  
nitric	   and	   sulfuric	   acids	   gives	   the	   first	   nitro	   compound	  7	   in	   70%	   yield.	   Hydrogenation	  
with	  Raney	  Nickel	  at	  60	  psi	  using	  the	  Parr	  shaker	  reduces	  the	  nitro	  group	  to	  the	  amino	  
group	  within	  4	  hours.	  The	  amino	  compound	  8	  is	  quickly	  used	  in	  the	  next	  step	  (or	  stored	  
at	  4⁰C),	   because	   it	   oxidizes	  easily.	  Another	  nitration,	  but	   at	   a	   lower	   temperature—	  at	  
10⁰C—is	  followed	  by	  the	  rearrangement	  of	  the	  nitro	  group	  in	  concentrated	  sulfuric	  acid.	  
Attempts	  were	  made	  to	  improve	  the	  yields	  in	  the	  latter	  reaction.	  The	  procedure55	  calls	  
for	  stirring	  9	  in	  sulfuric	  acid	  at	  room	  temperature	  for	  18-­‐48	  hours	  until	  complete.	  During	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these	   18-­‐48	   hours	   the	   formation	   of	   product	   is	   monitored	   by	   removing	   aliquots,	  
neutralizing	  with	  NH4OH,	  filtering	  and	  analyzing	  the	  precipitate	  by	  1H	  NMR.	  This	  method	  
of	   monitoring	   the	   reaction	   is	   very	   time	   consuming	   and	   proved	   to	   be	   unnecessary.	  
Contrary	   to	   the	   procedure	   description,55	   in	   all	   of	   the	   preparations	   of	   the	   rearranged	  
compound	  10	  during	  this	  project,	  the	  expected	  yield	  of	  50-­‐52%	  of	  the	  target	  compound	  
was	   invariably	  observed	  after	  only	  18	  hours	  without	  any	   increase	   in	  the	  yield	  over	  the	  
next	  30	  hours.	  The	  reaction	  time	  can	  be	  significantly	  reduced	  by	  altering	  the	  conditions.	  
First,	   the	   starting	   compound	  9	   is	   slowly	   dissolved	   in	   sulfuric	   acid,	   then	   the	  mixture	   is	  
gradually	  heated,	  and	  finally	  allowed	  to	  reflux	  for	  30	  minutes.	  The	  solution	  is	  allowed	  to	  
cool	   to	   room	   temperature,	   then	   neutralized	   with	   NH4OH	   and	   filtered.	   Refluxing	   the	  
solution	   for	   30	   min	   instead	   of	   stirring	   at	   room	   temperature	   overnight	   provides	   the	  
product	  faster,	  but	  unfortunately	  doesn’t	  give	  any	  significant	  increase	  in	  the	  yields.	  	  
In	  spite	  of	  the	  low	  yields	  obtained	  for	  compound	  10,	  the	  50%	  yields	  are	  sufficient	  for	  
the	   goals	   of	   the	   project.	   The	   reduction	   of	   compound	   10	   with	   stannous	   chloride	   in	  
concentrated	   hydrochloric	   acid	   is	   followed	   by	   refluxing	   the	   diamino	   product	   11	   in	  
triethylorthoformate	   and	   acetic	   anhydride.	   The	   cyclized	   compound	   12	   is	   transformed	  
into	   3-­‐methyl-­‐3-­‐deazaadenine	   13	   in	   two	   steps:	   by	   first	   refluxing	   12	   in	   anhydrous	  
hydrazine,	  then	  in	  water	  with	  Raney	  Nickel.	  Compounds	  7-­‐12	  can	  be	  purified	  in	  order	  to	  
obtain	   the	   best	   characterization	   data,	   but	   routinely,	   for	   faster	   results,	   product	   13	  
becomes	  the	  first	  one	  in	  this	  series	  to	  be	  purified	  by	  column	  chromatography.	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The	  next	   important	  step	   in	  the	  synthesis	   is	   the	  protection	  of	   the	  6-­‐amino	  group	   in	  
preparation	   for	   glycosylation.	   The	   tetramethylsuccinimide	   (M4SI)	   protecting	   group	  
(Scheme	  2)	  was	  developed	  in	  Prof.	  McLaughlin’s	  group	  and	  fulfills	  the	  requirements	  of	  
DNA	   synthesis	   protocol	   (see	   Chapter	   1).	   It	   is	   stable	   under	   mildly	   acidic	   and	   basic	  
conditions,	  but	  can	  be	  removed	  with	  ammonium	  hydroxide	  at	  55	  ⁰C.	  Moreover,	   it	  has	  
also	  been	  shown	  to	  be	  an	  efficient	  directing	  group	  during	  the	  glycosylation	  step40.	  The	  
bulky	  methyl	  groups	   restrict	  glycosylation	  at	  N7	  position	  of	   the	  heterocycle,	   therefore	  
increasing	  the	  yield	  of	  the	  desired	  N9	  isomer.	  	  
	  
Scheme	  2.	  The	  synthesis	  of	  2,2,3,3-­‐tetramethylsuccinic	  anhydride41	  
M4SI	  is	  installed	  at	  N6	  position	  of	  3-­‐deaza-­‐3-­‐methyladenine	  13	  by	  refluxing	  it	  with	  14	  
in	   pyridine	   in	   the	   presence	   of	   DBU	   (Scheme	   3).	   The	   original	   procedure55	   calls	   for	   an	  
additional	  step	  (see	  Chapter	  1,	  Scheme	  4):	  a	  small	  amount	  of	  the	  amide,	  resulting	  in	  the	  
reaction	   with	   pyridine	   and	   DBU,	   is	   converted	   to	   the	   imide	   in	   refluxing	   SOCl2.	   In	   this	  
research	   project	   the	   thionyl	   chloride	   step	   has	   been	   excluded	   due	   to	   its	   being	  
impractical.	  On	  one	  hand,	   the	  amount	  of	   the	  unwanted	  amide	   is	  very	  small	   (less	   than	  
3%).	  On	  the	  other	  hand,	  there	  are	  significant	  losses	  of	  the	  desired	  imide	  during	  column	  




Scheme	  3.	  The	  synthetic	  route	  to	  the	  functionalized	  (bromo)	  analogue	  
	  
The	   resulting	   3-­‐methyl-­‐3-­‐deazaadenine	   15	   with	   the	   installed	   M4SI	   is	   further	  
protected	  at	  N7/N9	  with	  a	  Boc	  protecting	  group.	  This	   is	  done	   in	  order	   to	   increase	  the	  
solubility	  of	  15	  in	  carbon	  tetrachloride	  in	  the	  next	  step.	  Radical	  bromination	  is	  achieved	  
by	   the	   treatment	   of	   15	   with	   N-­‐bromosuccinimide	   and	   benzoyl	   peroxide	   as	   a	   radical	  
initiator	  resulting	  in	  the	  brominated/	  functionalized	  molecule	  17.	  Finally,	  the	  Boc	  group	  
is	   removed	   by	   treatment	   with	   trifluoroacetic	   acid	   in	   DCM.	   Nucleobase	   18	   is	   a	   novel	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analogue	  that	  is	  suitable	  for	  further	  modification:	  bromide	  can	  be	  easily	  displaced	  by	  a	  
good	  nucleophile	  in	  an	  SN2	  reaction.	  	  
Previously,55	   the	   Boc	   group	   has	   been	   left	   on	   during	   further	   modification	   of	  
molecules.	   Specifically,	   the	   treatment	   of	   compound	   17	   with	   NaOAc	   in	   DMF	   at	   60⁰C	  
displaces	   the	  bromide	  as	  well	   as	   the	  Boc	  group	   (Scheme	  4).	   The	  acetate	  19	   is	   further	  
hydrolyzed	   with	   NH3/MeOH	   at	   room	   temperature	   for	   8	   hours	   to	   afford	   the	  
hydroxymethyl	  analogue	  20.	  
	  
Scheme	  4.	  Boc	  protecting	  group	  removal	  at	  elevated	  temperatures	  
However,	  the	  removal	  of	  the	  Boc	  group	  at	  an	  elevated	  temperature	  may	  not	  be	  ideal	  
for	   some	   of	   the	   more	   sensitive	   reactions.	   For	   example,	   a	   substitution	   with	   a	   strong	  
nucleophile,	   a	   kinetically	   controlled	   process,	   may	   quickly	   form	   additional	   unwanted	  
isomers	   or	   lead	   to	   decomposition	   at	   higher	   temperatures.	   The	   sensitivity	   of	   each	  
specific	   nucleophile	   to	   temperature	   should	   be	   taken	   into	   account	   as	   well.	   	   In	   this	  
project,	   the	   installation	   of	   the	   long	   thiol	   linker	   (vide	   infra)	   onto	  molecule	   17	   did	   not	  
succeed,	  most	  likely,	  due	  to	  the	  steric	  hindrance	  between	  the	  bulky	  nucleophile	  and	  Boc	  
group.	   On	   the	   other	   hand,	   after	   the	   removal	   of	   Boc,	   molecule	   18	   became	   a	   perfect	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substrate	   for	   the	   nucleophilic	   attack	   of	   the	   thio	   nucleophile	   21	   (Schemes	   5,	   6).	   Thus	  
compound	  18	  becomes	  a	  useful	  starting	  material	  for	  further	  modification	  of	  the	  purine	  
analogue.	  
	  
Scheme	  5.	  2-­‐mercaptoethanol	  is	  protected	  with	  TBDMS	  group	  
For	   the	   synthesis	   of	   the	   reactant	   21,	   2-­‐	   mercaptoethanol	   is	   protected	   with	  
tetrabutyldimethylsilyl	   group56	   (Scheme	   5).	   The	   reaction	   proceeds	   quantitatively	  
without	  any	  undesired	  protection	  on	  the	  sulfur	  because	  of	  the	  great	  affinity	  of	  silicon	  to	  
oxygen.	  The	  presence	  of	  thiol	   in	  21	  can	  be	  checked	  by	  Elman’s	  reagent,	  or	  DTNB	  (5,5'-­‐
Dithiobis-­‐(2-­‐Nitrobenzoic	  Acid)).	  Elman’s	  reagent	  is	  commonly	  used	  to	  quantitate	  thiols	  
in	   proteins,	   cells	   and	   plasma	   by	   absorption	   measurements.	   It	   readily	   forms	   a	   mixed	  
disulfide	   with	   thiols,	   liberating	   the	   chromophore	   5-­‐mercapto-­‐2-­‐nitrobenzoic	   acid	  
(absorption	  maximum	  410	  nm).	  In	  this	  project,	  there	  is	  no	  need	  to	  quantitate	  thiols,	  but	  
simply	   their	   presence	   can	   be	   detected	   by	   mixing	   a	   small	   amount	   of	   DTNB	   and	   21	  
affording	  a	  solution	  of	  a	  bright	  red	  color.	  
The	  next	  step	  installs	  the	  hydroxyethanol	  thio	  linker:	  21	  is	  first	  treated	  with	  DBU	  in	  
DMF	  for	  1	  hour,	  then	  stirring	  the	  mixture	  with	  the	  starting	  nucleobase	  for	  3	  hours	  gives	  
modified	  nucleobase	  22	  (Scheme	  6).	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Glycosylation	   is	   a	   particularly	   difficult	   reaction	   in	   the	   case	   of	   modified	   2’-­‐deoxy	  
purines	   (see	   Chapter	   1)	   because	   it	   must	   be	   both	   regio-­‐	   and	   diastereoselective.	   The	  
formation	  of	  four	  different	  isomers	  is	  possible	  and	  the	  separation	  is	  difficult.	  The	  sodium	  
salt	   method14	   used	   in	   this	   project	   gave	   good	   yields	   of	   the	   desired	   β-­‐N9	   nucleoside.	  
Nucleobase	   22	   is	   treated	   with	   NaH	   in	   MeCN	   (Scheme	   6)	   followed	   by	   addition	   of	  
chlorosugar57	  23.	  After	   stirring	   for	  about	  10	  hours,	  TLC	   shows	  complete	  conversion	  of	  
the	  starting	  material.	  The	  desired	  β-­‐N9	  isomer	  is	  obtained	  in	  70%	  yield.	  After	  the	  work	  
up,	  it	  is	  separated	  from	  the	  rest	  of	  the	  products	  by	  flash	  chromatography	  in	  1:1	  hexane-­‐
ethyl	  acetate	  solvent	  system.	  The	   identity	  of	  24	  was	  confirmed	  by	  examining	  2D	  COSY	  
and	  NOESY	  NMR	  spectra	  (see	  Table	  2).	  
The	  M4SI	   group	   stays	   on	  when	   the	   tolouyl	   groups	   are	   removed	   by	   the	   treatment	  
with	  a	  solution	  of	  7M	  ammonia	   in	  methanol	  at	   room	  temperature	  to	  yield	  78%	  of	  25.	  
Protection	  of	  the	  5′-­‐OH	  with	  the	  acid-­‐labile	  DMT	  group	  must	  be	  performed	  in	  very	  dry	  
reaction	  conditions.	  Starting	  material	  25	  is	  co-­‐evaporated	  with	  pyridine	  at	  least	  twice	  to	  




Scheme	  6.	  The	  formation	  of	  the	  novel	  phosphoramidite	  27	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hydroxyl	   groups	   in	  25,	   therefore	   reacts	   faster	  with	  DMT-­‐Cl	   reagent.	  A	   straightforward	  






Table	  2.	  2D	  NOESY.	  Selected	  important	  NOESY	  signals	  are	  shown	  with	  arrows.	  






H2''(2.8) H3',	  H2',	  H1'
H3'	  (5.6) H8,	  H5'/5'',H2'' 	  
In	   order	   to	   investigate	   the	   effect	   of	   the	   new	  modified	   purine	   on	   duplex	   stability,	  
phosphoramidite	   27	   must	   be	   incorporated	   into	   an	   oligonucleotide.	   A	   modified	  
oligonucleotide	   is	   then	   annealed	   with	   its	   complementary	   oligonucleotide	   and	   the	  
duplex’s	  stability	  is	  measured	  by	  thermal	  denaturation	  (TM)	  studies.	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There	   are	   several	   factors	   that	   have	   to	   be	   considered	  when	   incorporating	  5	   into	   a	  
DNA	  duplex.	  The	  new	  side	  chain	  on	  the	  modified	  adenine	  is	  bulky,	  and	  it’s	  unclear	  how	  
it	  will	  be	   tolerated	   in	  an	  oligonucleotide	  strand	  and	   in	  a	  duplex.	   If	   this	  modification	   is	  
successfully	   installed	   in	   an	   oligonucleotide,	   how	  will	   the	   linker	  with	  many	   degrees	   of	  
freedom	  arrange	  itself	  in	  space?	  Where	  would	  the	  new	  hydrogen	  bonds	  form?	  Answers	  
to	   these	   questions	  would	   clarify	   the	   importance	   of	   hydration	   in	   stabilizing	   A-­‐T	   tracts,	  
and	  the	  ability	  of	  the	  minor	  groove	  to	  accommodate	  non-­‐natural	  functional	  groups.	  
The	   synthesis	   of	   a	  modified	  DNA	   sequence	   containing	  5	   has	   been	   attempted	   (see	  
chapter	  3,	  experimental	  section	  for	  the	  details).	  Sequences	  1-­‐3	  (Table	  3)	  were	  prepared	  
by	   solid-­‐phase	  DNA	   synthesis.	   The	  DNA	   synthesizer	   showed	  100	  %	   coupling	   efficiency	  
for	   the	   analogue	   5	   with	   the	   overall	   oligonucleotide	   yield	   at	   70%.	   Inspired	   by	   the	  
seemingly	  easy	  incorporation	  of	  the	  new	  analogue	  into	  an	  oligonucleotide	  sequence,	  we	  	  
	  
	   	   	   	   	   	  
Oligonucleotide	   Sequence	   MALDI-­‐TOF	  MS	  
1	   	   5'-­‐d(CCGGAAAACGCC)-­‐3'	   	   3623.35	   	  
2	   	   5'-­‐d(GGCCTTTTGCGG)-­‐3'	   	   3668.51	   	  
3	   	   5'-­‐d(CCGG5AAACGCC)-­‐3'	   	   3311.70	   	  
	  
Table	  3.	  Oligonucleotides’	  sequences:	  1	  and	  3	  are	  complementary	  to	  2,	  but	  in	  3	  one	  of	  
the	  adenines	  is	  replaced	  by	  5.	  
continued	  with	  the	  deprotection	  and	  purification	  steps.	  The	  treatment	  with	  ammonium	  
hydroxide	  overnight	  at	  55⁰C	  deprotected	  and	  cleaved	  the	  oligonucleotides	  from	  the	  CPG	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beads.	  The	  purification	  of	  the	  native	  and	  modified	  sequences	  was	  accomplished	  by	  HPLC	  





Figure	  6.	  The	  new	  adenine	  analogue	  hEtThm3c3A	  and	  TBDMS-­‐protected	  hEtThm3c3A	  
	  
The	   DMT-­‐protected	   12-­‐mers	   had	   retention	   times	   of	   about	   17.5	   minutes,	   except	   for	  
sequence	  3,	  which	   had	   a	   retention	   time	  of	   24	  min.	  We	   assumed	   this	  was	   due	   to	   the	  
presence	  of	  the	  TBS	  group	  (molecule	  5a,	  Figure	  6)	  remaining	  on	  the	  modified	  residue.	  
The	  collected	  oligonucleotide	  solutions	  were	  then	  reduced	  in	  volume	  and	  detritylated	  in	  
80%	  acetic	  acid	  for	  30	  min.	  	  
The	   resulting	   native	   oligonucleotides	  1	   and	  2	   were	   desalted	   (Sephadex	   G-­‐10)	   and	  
lyophilized.	  The	  entire	  product	  containing	  sequence	  3	  was	  divided	   into	  two	  parts.	  One	  
half	   was	   desalted	   and	   lyophilized	   just	   like	   the	   native	   sequences	   (TBDMS	   protecting	  
group	  stayed	  on).	  The	  other	  half	  was	  dissolved	  in	  1	  M	  TBAF	  in	  THF	  solution	  for	  3	  hours	  in	  
order	  to	  remove	  the	  TBDMS	  protecting	  group	  first,	  then	  desalted.	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In	   spite	   of	   the	   promising	   results	   shown	   by	   the	   DNA	   synthesizer	   and	   the	   HPLC	  
(complete	   incorporation	  of	  the	  novel	  phosphoramidite	  and	   longer	  retention	  times	  due	  
to	  TBDMS	  group	  on),	  MALDI-­‐TOF	  spectra	   showed	   that	   the	  modified	  nucleobase	  might	  
not	   have	   been	   incorporated.	   For	   the	   reasons	   that	   are	   still	   unclear,	   the	   mass	   of	   the	  
modified	   sequence	   did	   not	   have	   the	   correct	   mass.	   The	   product	   subjected	   to	   the	  
treatment	  with	  TBAF	  was	  decomposed.	  	  
	  
Conclusions	  and	  Outlook	  
Analogue	  5	  is	  thought	  to	  be	  a	  good	  candidate	  for	  probing	  the	  hydration	  in	  the	  minor	  
grove	  because	  of	   its	   long	   side	   chain	   containing	   a	   hydrogen	  bond	  donor	  postulated	   to	  
result	   in	  more	   favorable	  hydrogen	  bonding	   to	   the	  neighboring	   T,	   therefore	   increasing	  
the	  stability	  of	  the	  DNA	  duplex.	  Other	  molecules	  may	  become	  good	  mimics	  of	  water	  as	  
well,	   for	   example,	   analogue	   29	   (Scheme	   8).	   The	   modified	   purine	   28	   has	   been	  
successfully	   synthesized	   (see	   chapter	   3,	   experimental	   details)	   and	   the	   synthesis	   of	  




Scheme	  8.	  A	  possible	  synthesis	  of	  a	  new	  purine	  analogue	  	  
In	  summary,	  a	  novel	  purine	  analogue	  has	  been	  synthesized	  and	  tested	  in	  an	  oligonucleotide	  
strand	   with	   the	   goal	   of	   probing	   the	   hydration	   in	   the	   minor	   groove.	   Although	   the	   multi-­‐step	  
synthesis	   of	   the	   new	   adenine	   analogue	   5	   turned	   out	   to	   be	   a	   time-­‐consuming	   process,	   the	  
incorporation	  of	  this	  molecule	  in	  a	  DNA	  duplex	  may	  be	  useful	  for	  a	  better	  understanding	  of	  the	  
hydration	  of	  B-­‐form	  DNA.	   The	   attempted	   incorporation	  of	   the	  new	  analogue	   in	   a	  DNA	   strand	  







3.	  Experimental	  Details	  and	  Supporting	  Information	  
4-­‐Nitro-­‐3-­‐picoline	  N-­‐oxide	  (7).55	  To	  a	  flask	  containing	  3-­‐picoline	  N-­‐oxide	  
6	  (20	  g,	  183	  mmol)	  was	  slowly	  added	  100	  mL	  of	  concentrated	  H2SO4.	  While	  keeping	  the	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temperature	  below	  80	  °C,	  40	  mL	  of	  90%	  fuming	  HNO3	  was	  added.	  The	  reaction	  mixture	  
was	   then	   carefully	   heated	   to	   100°C	   until	   an	   exothermic	   reaction	   was	   observed	   with	  
evolution	   of	   a	   brown	   gas.	   The	   flask	   was	   removed	   from	   heat	   until	   the	   bubbling	   had	  
subsided,	  then	  heated	  at	  120	  °C	  for	  2	  h,	  after	  which	  it	  was	  cooled	  to	  room	  temperature	  
and	   poured	   over	   300	   g	   of	   crushed	   ice.	   This	   mixture	   was	   placed	   in	   an	   ice	   bath	   and	  
titrated	  with	   concentrated	   NH4OH	   until	   a	   yellow	   precipitate	   formed	   at	   basic	   pH.	   The	  
mixture	  was	  filtered	  and	  the	  solid	  collected	  and	  dried	  to	  yield	  19.74	  g	  (70%)	  of	  7.	  This	  
compound	   could	   be	   used	   directly	   for	   the	   next	   step;	   recrystallization	   from	   methanol	  
yielded	  analytically	  pure	  material.	   1H	  NMR	  (400	  MHz,	  acetone-­‐d6):	  δ	  8.29	  (s,	  1H),	  8.19	  
(m,	  1H),	  8.11(d,	  J=12	  Hz,	  1H),	  2.59	  (s,	  3H);	  MS	  (ESI):	  m/z	  154	  (M+).	  
	  
4-­‐Amino-­‐3-­‐methylpyridine	   (8).55	   Raney	   nickel	   2800	   (8.0	   g;	   CAUTION:	  
pyrophoric;	  weighed	  under	  tared	  volume	  of	  water)	  was	  added	  to	  100	  mL	  of	  methanol	  
and	  pre-­‐reduced	   in	  a	  Parr	  shaker	  with	  H2	  at	  60	  psi	   for	  5	  min.	  Compound	  10	   (8.0	  g,	  52	  
mmol)	  was	  added	  and	  reduced	  at	  65	  psi	  for	  4	  h.	  The	  mixture	  was	  then	  filtered	  through	  
Celite,	  washed	  thoroughly	  with	  methanol	  and	  dried	  in	  vacuo	  to	  obtain	  5.05	  g	  (90%)	  of	  a	  
slightly	  green	  solid.	  Compound	  8	   is	  oxidized	  easily;	  therefore	  it	  was	  purged	  with	  argon	  
and	  stored	  at	  4	  °C	  until	  used.	  1H	  NMR	  (400	  MHz,	  acetone-­‐d6):	  δ	  7.96	  (s,	  1H),	  7.94	  (d,	  J	  =	  




4-­‐Nitramino-­‐3-­‐methylpyridine	  (9).55	  Compound	  8	  (6.80	  g,	  63	  mmol)	  was	  
dissolved	  in	  51	  mL	  of	  concentrated	  H2SO4	  and	  cooled	  to	  5	  °C	  in	  a	  dry	  ice/ethanol	  bath.	  
70%	  HNO3	  (21	  mL)	  was	  added	  slowly	  to	  maintain	  the	  reaction	  temperature	  below	  10	  °C.	  
The	  reaction	  mixture	  was	  allowed	  to	  stir	  at	  10	  °C	  for	  1	  h	  and	  then	  poured	  onto	  200	  g	  of	  
crushed	  ice.	  Concentrated	  NH4OH	  was	  then	  added	  until	  a	  creamy	  off-­‐white	  precipitate	  
was	  formed	  at	  pH	  7.	  The	  mixture	  was	  filtered	  and	  the	  precipitate	  recrystallized	  from	  hot	  
water	  to	  yield	  7.72	  g	  (80%)	  of	  9.	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6):	  δ	  8.15	  (d,	  2H),	  8.00	  (d,	  J	  
=	  6.6	  Hz,	  1H),	  2.08	  (s,	  1H);	  MS	  (ESI):	  m/z	  =	  153	  (M+).	  
	  
3-­‐methyl-­‐5-­‐nitropyridin-­‐4-­‐amine	  (10).55	  Compound	  9	  (2.00	  g,	  13	  mmol)	  was	  
added	  to	  19	  mL	  of	  concentrated	  H2SO4	  in	  small	  portions	  to	  avoid	  decomposition	  of	  the	  
starting	  material.	  The	  mixture	  was	  allowed	  to	  stir	  at	  room	  temperature	  for	  18-­‐48	  h	  until	  
complete	   (reaction	   was	   monitored	   by	   removing	   aliquot,	   neutralizing	   with	   NH4OH,	  
filtering,	  and	  analyzing	  the	  precipitate	  by	  1H	  NMR)	  and	  then	  quenched	  by	  pouring	  over	  
200	  g	  of	   crushed	   ice.	   This	  mixture	  was	   then	   slowly	   titrated	  with	   concentrated	  NH4OH	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while	  cooling	   in	  an	  ethanol/dry	   ice	  bath.	  When	  the	  mixture	  reached	  pH	  6.5-­‐7	  a	  yellow	  
precipitate	  formed.	  This	  was	  filtered	  and	  dried	  to	  yield	  1.02	  g	  (52%)	  of	  10.	  1H	  NMR	  (400	  
MHz,	  DMSO-­‐d6):	  δ	  8.87	  (s,	  1H),	  8.09	  (s,	  1H),	  7.66	  (bs,	  2H),	  2.12	  (s,3H).	  MS	  (ESI):	  m/z	  153	  
(M+).	  
	  
2-­‐chloro-­‐5-­‐methylpyridine-­‐3,4-­‐diamine	   (11).55	   Anhydrous	   stannous	  
chloride	  (12.64	  g,	  66.7	  mmol,)	  was	  added	  to	  51	  mL	  of	  concentrated	  HCl	  followed	  by	  10	  
(3.4	  g,	  22	  mmol)	  was	  added	  and	  the	  reaction	  mixture	  heated	  at	  90	  °C	  for	  1.5	  h.	  TLC	  (9:1	  
DCM:MeOH)	   of	   an	   aliquot	   (pH	   adjusted	   to	   12	   and	   extracted	   with	   EtOAc)	   showed	  
complete	  consumption	  of	  starting	  material.	  The	  reaction	  mixture	  was	  allowed	  to	  cool	  to	  
room	   temperature	  and	  poured	  over	  475	  g	  of	   crushed	   ice.	   The	  pH	  was	  adjusted	   to	  12	  
with	   7	   M	   NaOH	   and	   the	   reaction	   mixture	   extracted	   with	   EtOAc	   (4	   x	   200	   mL).	   The	  
combined	  organic	   layers	  were	  dried	  with	  MgSO4,	   filtered,	  and	  dried	   in	  vacuo	  to	  afford	  
2.46	  g	  (70%)	  of	  white	  solid.	  In	  most	  cases	  the	  crude	  product	  was	  pure	  enough	  to	  be	  used	  
directly	   in	   the	   next	   step;	   otherwise,	   flash	   column	   chromatography	   eluting	   with	   9:1	  
DCM:MeOH	  gave	  pure	  11.	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6):	  δ	  7.20	  (s,	  1H),	  5.47	  (bs,	  2H),	  




4-­‐chloro-­‐7-­‐methyl-­‐1H-­‐imidazo[4,5-­‐c]pyridine	   (12)55.	   Under	   argon	  
atmosphere,	   20	  mL	   of	   anhydrous	   triethylorthoformate	   (distilled	   from	   Na)	   and	   20	   mL	  
acetic	   anhydride	   (fractionally	   distilled)	   was	   added	   to	   4.0	  g	   (25.4	  mmol)	   of	   11	   and	  
refluxed	  for	  1	  h.	  The	  reaction	  was	  cooled	  to	  room	  temperature	  and	  dried	  in	  vacuo.	  Flash	  
chromatography	  eluting	  with	  9:1	  DCM:MeOH	  yielded	  2.52	  g	  (63%)	  of	  12.	  1H	  NMR	  (400	  
MHz,	  DMSO-­‐d6):	  δ	  =	  13.3	  (bs,	  1H)	  8.45	  (s,	  1H),	  7.91	  (s,	  1H),	  2.44	  (s,	  3H).	  MS	  (ESI):	  m/z	  
167	  (M+).	  
	  
7-­‐methyl-­‐1H-­‐imidazo[4,5-­‐c]pyridin-­‐4-­‐amine	   (13).	   To	   a	   flask	   containing	   4-­‐
chloro-­‐7-­‐methyl-­‐1H-­‐imidazo[4,5-­‐c]pyridine	  12	   (1.50	  g,	  7.49	  mmol)	  was	  added	  25	  mL	  of	  
anhydrous	  hydrazine.	  The	  mixture	  was	  heated	  to	  reflux	  for	  30	  h.	  Excess	  hydrazine	  was	  
removed	  in	  vacuo	  and	  co-­‐evaporated	  with	  EtOH	  (3	  x	  15	  mL).	  Water	  (45	  mL)	  and	  Raney	  
nickel	  (2.25	  g,	  CAUTION:	  pyrophoric,	  weighed	  under	  tared	  volume	  of	  water)	  were	  added	  
and	   the	  mixture	  heated	   to	   reflux	  with	   vigorous	   stirring	   to	   prevent	   the	  Raney	  Ni	   from	  
sticking	  to	  the	  stir	  bar.	  After	  3	  h	  the	  mixture	  was	  filtered,	  while	  still	  hot,	  through	  a	  pad	  
of	   Celite	   and	   the	   pad	  washed	  with	   200	  mL	   of	   hot	   water	   (CAUTION:	   prevent	   leftover	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Raney	  Ni	  from	  drying).	  Evaporation	  of	  volatiles	  in	  vacuo	  afforded	  a	  brown	  solid.	  This	  was	  
re-­‐dissolved	  in	  minimal	  MeOH	  and	  9	  g	  of	  silica	  gel	  were	  added.	  After	  thorough	  drying	  of	  
the	  mixture	  the	  resulting	  fine	  powder	  was	   loaded	  onto	  a	  flash	  column	  and	  purified	  by	  
elution	   with	   9:1	   DCM:MeOH	   containing	   0.7	   M	   NH3.	   Evaporation	   of	   the	   appropriate	  
fractions	  afforded	  13	  as	  a	  white	  amorphous	  powder	  (743	  mg,	  67%)	  and	  starting	  material	  
(400	  mg,	  13%).	  1H	  NMR	  (DMSO-­‐d6,	  400	  MHz):	  δ	  12.55	  (brs,	  1H),	  8.08	  (s,	  1H),	  7.42	  (s,	  1H),	  
5.86	  (brs,	  2H),	  2.26	  (s,	  3H)	  ppm;	  13C	  NMR	  (DMSO-­‐d6,	  101	  MHz)	  δ	  150.79,	  140.69,	  139.39,	  
126.57,	   108.00,	   14.55	   ppm;	  HRMS	   (DART-­‐TOF)	   calcd	   for	   C7H9N4H+	   [M	  +	  H]+	   149.0827,	  
found:	  149.0834.	  
	  
To	  a	  flask	  containing	  13	   (0.69	  g,	  4.66	  mmol)	  and	  anhydride	  14	  (1.5	  g,	  9.6	  
mmol)	  was	  added	  pyridine	  (50	  mL)	  and	  DBU	  (2.1	  mL).	  The	  mixture	  was	  heated	  to	  reflux	  
for	  18	  h.	  Volatiles	  were	  removed	  	  in	  vacuo	  	  and	  the	  residue	  co-­‐evaporated	  with	  toluene	  
(3	  x	  10	  mL)	   to	   remove	   residual	  pyridine.	  The	   resulting	  brown	  oil	  was	  purified	  by	   flash	  
column	   chromatography	  eluting	  with	  95:5	  DCM:MeOH	   to	  obtain	  1.1	   g	   (85%)	  of	  white	  
solid.	   1H	  NMR	  (acetone-­‐d6,	  400	  MHz)	  δ	  8.27	   (s,	  1H),	  8.12	   (s,	  1H),	  2.57	   (s,	  3H),	  1.33	   (s,	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12H);	   13C	  NMR	   (acetone-­‐d6,	   101	  MHz)	   δ	   182.63,	   145.10,	   142.18,	   49.06,	   22.47,	   14.94;	  
HRMS	  (DART-­‐TOF)	  calcd	  for	  C15H19N4O2H+	  [M	  +	  H]+	  287.1508,	  found:	  287.1508.	  
	  
tert-­‐butyl	   7-­‐methyl-­‐4-­‐(3,3,4,4-­‐tetramethyl-­‐2,5-­‐dioxopyrrolidin-­‐1-­‐yl)-­‐
1H-­‐imidazo[4,5-­‐c]pyridine-­‐1-­‐carboxylate	   and	   tert-­‐butyl	   7-­‐methyl-­‐4-­‐(3,3,4,4-­‐
tetramethyl-­‐2,5-­‐dioxopyrrolidin-­‐1-­‐yl)-­‐3H-­‐imidazo[4,5-­‐c]pyridine-­‐3-­‐carboxylate	  (16).	  To	  
a	   flask	   containing	  15	   (2.85	   g,	   9.95	  mmol)	  was	   added	   Boc2O	   (3.04	   g,	   13.9	  mmol)	   and	  
DMAP	  (243	  mg,	  1.99	  mmol).	  DCM	  (52	  mL)	  was	  added	  andt	  he	  mixture	  stirred	  at	  rt	  for	  30	  
min	   (anhydrous	   conditions	   not	   needed).	   The	   starting	   material	   gradually	   dissolved	   to	  
produce	  a	  yellow	  homogeneous	  solution.	  TLC	  (97:3	  DCM:	  MeOH)	  indicated	  that	  a	  small	  
amount	  of	  starting	  material	  remained.	  More	  Boc2O	  (1.1	  g,	  5	  mmol)	  and	  DMAP	  (122	  mg,	  
1	  mmol)	  were	  added	  to	  drive	  the	  reaction	  to	  completion.	  After	  allowing	  the	  mixture	  to	  
stir	  for	  another	  15	  min,	  TLC	  indicated	  that	  no	  starting	  material	  remained.	  Volatiles	  were	  
removed	  in	  vacuo	  and	  the	  residue	  purified	  by	  flash	  column	  chromatography	  eluting	  with	  
97.5:2.5	   DCM:MeOH	   to	   afford	   the	   desired	   product	   as	   a	   white	   foam	   (3.27	   g,	   85%,	  
mixture	  of	  N7/N9	  regioisomers).	  5:	  Rf	  =	  0.29,	  0.36	  (silica	  gel,	  97:3	  DCM:MeOH);	  1H	  NMR	  
(CDCl3,	  400	  MHz):	  δ	  8.41	  (s,	  0.5H),	  8.39	  (d,	  J	  =	  0.8	  Hz,	  0.5H),	  8.38	  (s,	  1H),	  8.32	  (d,	  J	  =	  0.8	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Hz,	  1H),	  2.73	  (d,	  J	  =	  0.8	  Hz,	  3H),	  2.63	  (d,	  J	  =	  0.8	  Hz,	  1.5H),	  1.64	  (s,	  9H),	  1.60	  (s,	  4.4H),	  1.39	  
–	  1.29	   (m,	  17.8H)	  ppm;	  13C	  NMR	  (CDCl3,	  101	  MHz)	  δ	  181.62,	  181.46,	  151.92,	  146.67,	  
146.31,	  145.86,	  145.27,	  144.91,	  143.76,	  138.26,	  137.65,	  137.47,	  130.87,	  126.75,	  121.55,	  
86.96,	  86.66,	  81.05,	  47.98,	  46.73,	  28.05,	  27.98,	  27.96,	  27.81,	  22.63,	  21.66,	  21.51,	  18.87,	  






1Himidazo[4,5-­‐c]pyridine-­‐1-­‐carboxylate	  and	  tert-­‐butyl	  7-­‐(bromomethyl)-­‐4-­‐(3,3,4,4-­‐	  
tetramethyl-­‐2,5-­‐dioxopyrrolidin-­‐1-­‐yl)-­‐3H-­‐imidazo[4,5-­‐c]pyridine-­‐3-­‐carboxylate	  (17).	  To	  
a	   flask	   containing	  16	   (3.27	  g,	   8.46	  mmol)	  was	  added	  N-­‐bromosuccinimide	   (1.28	  g,	   7.2	  
mmol,	  recrystallized	  from	  hot	  H2O),	  benzoyl	  peroxide	  (131	  mg,	  0.54	  mmol),	  and	  175	  mL	  
of	  CCl4	   (reagent	  grade,	  not	  anhydrous).	  The	  mixture	  was	  heated	  to	  reflux	  with	  stirring.	  
After	   3	   h	   additional	   NBS	   (301	  mg,	   1.69	  mmol)	   and	   (BzO)2	   (31	  mg,	   0.127	  mmol)	  were	  
added.	   The	   reaction	   was	   carefully	   monitored	   by	   TLC	   (97:3	   DCM:MeOH)	   afterwards.	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After	   6.5	   h	   total	   the	   reaction	   was	   virtually	   complete,	   with	   only	   a	   trace	   of	   starting	  
material	   and	  a	   trace	  of	  undesired	  dibrominated	  product.	  The	   reaction	  was	  allowed	   to	  
cool	  to	  rt	  and	  filtered	  to	  removed	  succinimide.	  Volatiles	  were	  removed	  in	  vacuo	  and	  the	  
residue	  purified	  by	  flash	  column	  chromatography	  eluting	  with	  DCM→97:3	  DCM:MeOH	  
to	   afford	   the	   desired	   product	   as	   a	   white	   foam	   (2.78	   g,	   71%,	   mixture	   of	   N7/N9	  
regioisomers),	  as	  well	  as	  the	  dibrominated	  product	  as	  an	  off-­‐white	  solid	  (357	  mg,	  7.7%,	  
mixture	  of	  N7/N9	  regioisomers).	  6:	  Rf	  =	  0.36,	  0.43	  (silica	  gel,	  97:3	  DCM:MeOH);	  1H	  NMR	  
(CDCl3,	  400	  MHz)	  δ	  8.61	  (s,	  1H),	  8.50	  (s,	  1H),	  8.49	  (s,	  0.5H),	  8.41	  (s,	  0.5H),	  5.13	  (s,	  1H),	  
4.90	  (s,	  2H),	  1.70	  (s,	  4.5H),	  1.62	  (s,	  9H),	  1.42	  –	  1.30	  (m,	  18H)	  ppm;	  13C	  NMR	  (101	  MHz,	  
cdcl3	  δ	  181.27,	  181.08,	  151.19,	  146.01,	  145.47,	  144.84,	  143.69,	  139.70,	  132.91,	  126.07,	  
125.29,	  121.49,	  87.70,	  87.03,	  48.02,	  46.78,	  29.46,	  27.92,	  27.88,	  27.85,	  23.84,	  22.45,	  
21.51,	  21.37,	  18.80	  ppm;	  HRMS	  (DART-­‐TOF)	  calcd	  for	  C20H25Br1N4O4H+	  [M	  -­‐	  Boc	  +	  
H]+	  467.11170,	  found:	  467.11272.	  
	  
1-­‐(7-­‐(bromomethyl)-­‐1H-­‐imidazo[4,5-­‐c]pyridin-­‐4-­‐yl)-­‐3,3,4,4-­‐
tetramethylpyrrolidine-­‐2,5-­‐dione	  (12).	  Compound	  17	  (1.11	  g,	  2.38	  mmol)	  was	  dissolved	  
in	  20	  ml	  of	  dichloromethane.	  While	  stirring,	  trifluoroacetic	  acid	  (4	  ml)	  was	  added	  drop	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wise.	  The	  mixture	  was	  allowed	  to	  stir	  at	   room	  temperature	   for	  30	  min,	  at	  which	   time	  
TLC	   (5:95	   MeOH:DCM)	   indicated	   that	   all	   starting	   material	   had	   been	   consumed.	   The	  
reaction	  was	  quenched	  by	  the	  addition	  of	  saturated	  solution	  of	  sodium	  bicarbonate.	  The	  
resulting	   mixture	   was	   extracted	   with	   dichloromethane,	   washed	   with	   water	   and	  
saturated	   solution	   of	   sodium	   chloride.	   The	   organic	   layer	   was	   dried	   with	   anhydrous	  
sodium	  sulfate,	  filtered,	  and	  dried	   in	  vacuo.	  The	  crude	  product	  was	  purified	  by	  column	  
chromatography	  (3:97	  MeOH:DCM)	  to	  afford	  the	  title	  compound	  as	  a	  white	  foam	  (810	  
mg,	  93%).	  1H	  NMR	  (400	  MHz,	  Chloroform-­‐d)	  δ	  8.28	  (s,	  1H),	  7.74	  (s,	  1H),	  4.59	  (s,	  2H),	  1.34	  
(s,	  12H).	  13C	  NMR	  (101	  MHz,	  Chloroform-­‐d)	  δ	  182.16	  ,	  143.60	  ,	  141.05	  ,	  76.91	  ,	  48.25	  ,	  
25.78	  ,	  21.73	  .	  HRMS	  (ESI-­‐TOF)	  calcd	  for	  C15H18BrN4O2	  365.06131,	  found:	  365.06199.	  
	  
1-­‐(7-­‐(((2-­‐((tert-­‐butyldimethylsilyl)oxy)ethyl)thio)methyl)-­‐1H-­‐
imidazo[4,5-­‐c]pyridin-­‐4-­‐yl)-­‐3,3,4,4-­‐tetramethylpyrrolidine-­‐2,5-­‐dione	  (22).	  To	  a	  dry	  flask	  
containing	  2-­‐((tert-­‐butyldimethylsilyl)oxy)ethanethiol	  21	  (95mg,	  0.41	  mmol)	  and	  2	  ml	  of	  
DMF	   under	   inert	   atmosphere	   was	   added	   DBU	   (85	   µL,	   0.57	   mmol).	   The	   mixture	   was	  
stirred	  at	  room	  temperature	  for	  30	  min.	   	  Then	  compound	  18	  dissolved	  in	  2	  ml	  of	  DMF	  
was	  added	  to	  the	  mixture	  drop	  wise	  and	  stirred	  for	  3	  hrs.	  The	  reaction	  was	  quenched	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with	  saturated	  solution	  of	  sodium	  bicarbonate,	  extracted	  with	  DCM,	  washed	  with	  water	  
and	  saturated	  solution	  of	  sodium	  chloride.	  The	  organic	  layer	  was	  dried	  with	  anhydrous	  
sodium	  sulfate	  and	  filtered.	  Volatiles	  were	  removed	  in	  vacuo	  and	  the	  residue	  purified	  by	  
column	   chromatography	   (97:3	   DCM:MeOH)	   to	   afford	   178	  mg	   (91%)	   of	   22	   as	   a	  white	  
solid.	  	  1H	  NMR	  (400	  MHz,	  Chloroform-­‐d)	  δ	  8.14	  (s,	  1H),	  7.72	  (s,	  1H),	  3.91	  (s,	  2H),	  3.77	  (t,	  J	  
=	  6.2	  Hz,	  2H),	  2.48	  (t,	   J	  =	  6.2	  Hz,	  2H),	  1.31	  (s,	  12H),	  0.86	  (s,	  9H),	  0.07	  (s,	  6H).	  13C	  NMR	  
(101	  MHz,	   Chloroform-­‐d)	   δ	   182.11	   ,	   143.32	   ,	   140.70	   ,	   120.81	   ,	   77.55	   ,	   63.71	   ,	   48.06	   ,	  
33.96	   ,	   30.46	   ,	   26.08	   ,	   21.65	   ,	   18.53	   ,	   -­‐5.09.	   HRMS	   (ESI-­‐TOF)	   calcd	   for	   C23H37N4O3SSi	  





3-­‐yl	   4-­‐methylbenzoate	   (24).	   Compound	   22	   (200	  mg,	   0.42	  mmol)	   was	   combined	  with	  
NaH	  (42	  mg	  dispersion	  in	  mineral	  oil,	  0.88	  mmol)	  under	  N2	  atmosphere.	  Dry	  acetonitrile	  
(3	  ml)	  was	  added	  and	   the	  mixture	  was	   stirred	  at	   room	   temperature	   for	  1	  hr.	   Then	  α-­‐
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chloro	  sugar	  23	  (342	  mg,	  0.88	  mmol)	  dissolved	  in	  2	  ml	  of	  MeCN	  was	  added	  dropwise	  to	  
the	   flask.	   The	  mixture	   was	   stirred	   overnight,	   after	   which	   the	   reaction	   was	   quenched	  
with	   ammonium	   chloride.	   The	   resulting	   mixture	   was	   extracted	   with	   ethyl	   acetate,	  
washed	  with	  water	   and	   saturated	   solution	   of	   sodium	   chloride.	   The	   organic	   layer	  was	  
dried	  with	   anhydrous	   sodium	   sulfate,	   filtered,	   and	   dried	   in	   vacuo.	   The	   crude	   product	  
was	   purified	   by	   column	   chromatography	   (1:1	  Hexane:EtOAc)	   to	   afford	  14	   as	   a	   yellow	  
foam	  (238	  mg,	  70%).	  1H	  NMR	  (500	  MHz,	  Chloroform-­‐d)	  δ	  8.22	  (d,	  J	  =	  4.9	  Hz,	  2H),	  7.99	  –	  
7.92	  (m,	  2H),	  7.87	  –	  7.81	  (m,	  2H),	  7.24	  (dd,	  J	  =	  23.7,	  8.0	  Hz,	  4H),	  6.86	  (dd,	  J	  =	  8.3,	  5.3	  Hz,	  
1H),	  5.70	  (dt,	  J	  =	  5.7,	  2.4	  Hz,	  1H),	  4.66	  –	  4.51	  (m,	  3H),	  4.30	  (d,	  J	  =	  13.7	  Hz,	  1H),	  4.11	  –	  
4.01	   (m,	  1H),	  3.80	   (qt,	   J	  =	  10.5,	  6.2	  Hz,	  2H),	  2.92	   (ddd,	   J	  =	  13.7,	  5.3,	  2.5	  Hz,	  1H),	  2.83	  
(ddd,	  J	  =	  14.0,	  8.3,	  6.0	  Hz,	  1H),	  2.69	  –	  2.52	  (m,	  2H),	  2.40	  (d,	  J	  =	  14.8	  Hz,	  7H),	  2.15	  (s,	  1H),	  
1.38	   –	   1.18	   (m,	   18H),	   0.87	   (s,	   12H),	   0.07	   (d,	   J	   =	   1.8	   Hz,	   6H).	   13C	   NMR	   (101	   MHz,	  
Chloroform-­‐d)	   δ	   181.49	   (d,	   J	   =	   16.1	   Hz),	   166.32	   ,	   166.04	   ,	   145.06	   ,	   144.81	   ,	   144.41	   ,	  
143.56	  ,	  142.27	  ,	  139.36	  ,	  139.07	  ,	  137.96	  ,	  130.38	  –	  129.96	  (m),	  129.81	  (d,	  J	  =	  3.6	  Hz),	  
129.67	  –	  129.21	  (m),	  126.75	  ,	  126.50	  (d,	  J	  =	  3.8	  Hz),	  119.54	  ,	  85.98	  ,	  84.32	  (d,	  J	  =	  11.3	  
Hz),	  82.89	  ,	  82.63	  ,	  77.55	  ,	  74.78	  ,	  74.51	  (d,	  J	  =	  12.8	  Hz),	  64.15	  ,	  63.95	  ,	  63.56	  ,	  56.18	  ,	  
53.53	  ,	  53.16	  ,	  48.18	  (d,	  J	  =	  5.8	  Hz),	  38.86	  ,	  36.83	  ,	  33.92	  ,	  32.15	  (d,	  J	  =	  3.4	  Hz),	  31.23	  ,	  
29.89	  (d,	  J	  =	  4.4	  Hz),	  29.57	  ,	  26.13	  ,	  23.03	  –	  22.77	  (m),	  22.05	  –	  21.47	  (m),	  18.52	  (d,	  J	  =	  3.0	  
Hz),	  14.37	   (d,	   J	  =	  7.8	  Hz),	   -­‐4.98	  –	   -­‐5.42	   (m).	  HRMS	  (ESI-­‐TOF)	  calcd	   for	  C44H56N4O8NaSiS	  








tetramethylpyrrolidine-­‐2,5-­‐dione	  (25).	  To	  a	  dry	  flask	  containing	  24	  (268	  mg,	  0.32	  mmol)	  
was	  added	  4	  mL	  of	  MeOH	  with	  7	  M	  NH3.	  The	  flask	  was	  tightly	  stoppered	  and	  the	  mixture	  
allowed	   to	   stir	   at	   room	   temperature	  overnight.	   TLC	   indicated	   complete	   conversion	   to	  
25.	   Volatiles	   were	   removed	   in	   vacuo	   and	   the	   residue	   purified	   by	   column	  
chromatography	  eluting	  with	  (97:3	  DCM:MeOH)	  to	  afford	  25	  as	  a	  white	  foam	  (147	  mg,	  
78%).	   1H	  NMR	  (400	  MHz,	  Methanol-­‐d4)	  δ	  8.68	  (s,	  1H),	  8.17	   (s,	  1H),	  6.76	   (t,	   J	  =	  6.3	  Hz,	  
1H),	  4.52	  (dt,	  J	  =	  6.0,	  4.0	  Hz,	  1H),	  4.34	  (d,	  J	  =	  13.6	  Hz,	  1H),	  4.11	  (d,	  J	  =	  13.6	  Hz,	  1H),	  4.00	  
(q,	  J	  =	  3.6	  Hz,	  1H),	  3.80	  –	  3.55	  (m,	  4H),	  2.79	  –	  2.51	  (m,	  4H),	  1.34	  –	  1.29	  (m,	  13H),	  0.85	  (s,	  
9H),	   0.07	   (d,	   J	   =	   1.8	   Hz,	   6H).	   	   13C	   NMR	   (101	  MHz,	  Methanol-­‐d4)	   δ	   183.35	   ,	   146.01	   ,	  
143.55	  ,	  140.61	  ,	  139.18	  (d,	  J	  =	  11.9	  Hz),	  122.32	  ,	  89.58,	  87.67	  ,	  72.19	  ,	  64.80	  ,	  64.58	  ,	  
62.84	  ,	  49.79	  ,	  42.01	  ,	  35.10	  ,	  31.57	  ,	  30.87	  ,	  26.56	  ,	  22.01	  (d,	  J	  =	  2.3	  Hz),	  19.30	  ,	  -­‐4.98	  (d,	  







1H-­‐imidazo[4,5-­‐c]pyridin-­‐4-­‐yl)-­‐3,3,4,4-­‐tetramethylpyrrolidine-­‐2,5-­‐dione	   (26).	  
Compound	  25	   (200	  mg,	   0.34	  mmol)	  was	   co-­‐evaporated	  with	  pyridine	   twice	   to	   ensure	  
dry	  reaction	  conditions.	  Then	  5	  ml	  of	  pyridine	  was	  added	  to	  the	  flask,	  followed	  by	  DMAP	  
(10	  mg,	  0.08	  mmol)	  and	  DMTCl	   (138	  mg,	  0.41	  mmol).	  The	  mixture	  was	  allowed	  to	  stir	  
overnight,	  after	  which	  the	  reaction	  was	  quenched	  with	  water.	  The	  resulting	  mixture	  was	  
extracted	  with	  DCM,	  washed	  with	  water	  and	  saturated	  solution	  of	  sodium	  chloride.	  The	  
organic	  layer	  was	  dried	  with	  anhydrous	  sodium	  sulfate,	  filtered,	  and	  dried	  in	  vacuo.	  The	  
crude	  product	  was	  purified	  by	  column	  chromatography	  (silica	  gel	  washed	  with	  1%	  TEA	  in	  
98:2	  DCM:MeOH,	  then	  eluted	  with	  two	  column	  volumes	  of	  solvent	  system	  without	  TEA	  
before	  loading	  compound)	  eluting	  with	  98:2	  DCM:MeOH	  to	  afford	  26	  (252	  mg,	  84%)	  as	  a	  
white	  foam.	  1H	  NMR	  (400	  MHz,	  Chloroform-­‐d)	  δ	  8.21	  (s,	  1H),	  8.13	  (s,	  1H),	  7.39	  –	  7.32	  (m,	  
2H),	  7.30	  –	  7.14	  (m,	  7H),	  6.83	  –	  6.75	  (m,	  4H),	  6.70	  (t,	  J	  =	  6.2	  Hz,	  1H),	  4.52	  (q,	  J	  =	  5.0	  Hz,	  
1H),	  4.27	  (d,	  J	  =	  13.3	  Hz,	  1H),	  4.14	  –	  3.99	  (m,	  2H),	  3.91	  –	  3.74	  (m,	  8H),	  3.41	  –	  3.31	  (m,	  
1H),	  3.25	  (dd,	  J	  =	  10.1,	  5.3	  Hz,	  1H),	  2.75	  –	  2.54	  (m,	  4H),	  1.31	  (s,	  12H),	  0.90	  (d,	  J	  =	  1.2	  Hz,	  
54	  
	  
9H),	   0.07	   (d,	   J	   =	   1.8	   Hz,	   6H).	   13C	   NMR	   (101	  MHz,	   Chloroform-­‐d)	   δ	   221.72	   ,	   181.63	   ,	  
178.71	  ,	  158.82	  ,	  145.36	  ,	  144.56	  ,	  143.28	  ,	  142.58	  ,	  139.23	  ,	  138.86	  ,	  138.04	  ,	  135.66,	  
130.18,	  128.20,	  127.23	  ,	  119.53	  ,	  113.50,	  87.96	  ,	  86.94	  ,	  85.90	  ,	  85.58	  ,	  76.91	  ,	  72.57	  ,	  
63.96	  ,	  63.58	  ,	  55.44	  ,	  48.14,	  41.07	  ,	  34.19	  ,	  31.23	  ,	  26.18,	  21.88	  ,	  21.53	  ,	  18.59	  ,	  -­‐5.02	  .	  







1-­‐yl)-­‐1H-­‐imidazo[4,5-­‐c]pyridin-­‐1-­‐yl)tetrahydrofuran-­‐3-­‐yl	   (2-­‐cyanoethyl)	  
diisopropylphosphoramidite	   (27).	   To	   a	   flask	   containing	   26	   (30	   mg,	   0.034	   mmol)	  
dissolved	   in	  MeCN	   (0.5	  mL)	   was	   added	   tetrazole	   (67µL	   of	   0.45	  M	   solution	   in	  MeCN,	  
0.031	  mmol)	   followed	  by	  2-­‐cyanoethyl	  N,N,N,N-­‐tetraisopropylphosphane	  (21	  µL,	  0.068	  
55	  
	  
mmol).	  The	  mixture	  was	  allowed	  to	  stir	  at	  room	  temperature	  overnight,	  after	  which	  TLC	  
indicated	  that	  the	  reaction	  was	  complete.	  MeOH	  was	  added	  and	  stirring	  continued	  for	  5	  
min.	  The	  mixture	  was	  extracted	  with	  DCM,	  washed	  with	  saturated	  NaHCO3	  and	  brine.	  
The	  organic	  layer	  was	  dried	  with	  anhydrous	  Na2SO4	  and	  filtered.	  Volatiles	  were	  removed	  
in	  vacuo	  and	  the	  residue	  purified	  by	  column	  chromatography	  (silica	  gel	  washed	  with	  1%	  
TEA	   in	   99.5:0.5	   DCM:MeOH,	   then	   eluted	   with	   two	   column	   volumes	   of	   the	   solvent	  
system	  without	  TA	  before	   loading	  the	  compound)	  eluting	  with	  95.5:0.5	  DCM:MeOH	  to	  
afford	  27	   as	   a	  white	   foam	   (28	  mg,	  81%,	  1:1	  mixture	  of	  diastereomers).	   31P	  NMR	   (162	  
MHz,	   Chloroform-­‐d)	   δ	   149.269,	   149.710	   ppm.	   HRMS	   (DART-­‐TOF)	   calcd	   for	  





To	  the	  flask	  containing	  18	  (200	  mg,	  0.55	  mmol),	  KCN	  (54	  mg,	  0.82	  mmol),	  and	  18-­‐crown-­‐
6	  ether	  (217	  mg,	  0.82	  mmol)	  was	  added	  5.5	  ml	  DMF.	  The	  mixture	  was	  allowed	  to	  stir	  at	  
room	   temperature	   for	   2	   hours.	   Solvent	   was	   evaporated	   and	   the	   crude	   product	   was	  
56	  
	  
purified	  by	  column	  chromatography	  (MeOH:DCM	  2:98).	  	  1H	  NMR	  (500	  MHz,	  DMSO-­‐d6)	  δ	  
13.52	   (s,	   1H),	   8.51	   (s,	   1H),	   8.24	   (s,	   1H),	   4.35	   (s,	   2H),	   1.34	   (s,	   12H).	  MS	   calculated	   for	  
















Sequences	   1-­‐3	   (Table	   1)	   were	   prepared	   by	   solid-­‐phase	   DNA	   synthesis.	   The	  
conditions	   for	   the	   incorporation	   of	   analogue	   nucleotide	   containing	   modified	   base	   5	  
(Figure	  1)	  were	  changed:	  the	  wait	  time	  during	  coupling	  cycle	  was	  increased	  to	  2	  hours	  
from	  standard	  2	  minutes	  used	   for	   the	  native	  sequences.	  The	  DNA	  synthesizer	  showed	  
100	  %	  coupling	  efficiency	  for	  the	  	  
	  
Oligonucleotide	   Sequence	   MALDI-­‐TOF	  MS	  
1	   	   5'-­‐d(CCGGAAAACGCC)-­‐3'	   	   3623.35	   	  
2	   	   5'-­‐d(GGCCTTTTGCGG)-­‐3'	   	   3668.51	   	  
3	   	   5'-­‐d(CCGG5AAACGCC)-­‐3'	   	   3311.70	   	  
	  
Table	  1.	  Oligonucleotides’	  sequences:	  1	  and	  3	  are	  complementary	  to	  2,	  but	  in	  3	  one	  of	  
the	  adenines	  is	  replaced	  by	  5.	  
	  
analogue	  5	  with	  the	  overall	  oligonucleotide	  yield	  at	  70%.	  Inspired	  by	  the	  seemingly	  easy	  
incorporation	  of	  the	  new	  analogue	  into	  an	  oligonucleotide	  sequence,	  we	  continued	  with	  
the	  following	  steps.	  After	  the	  DNA	  synthesizer	  reactions	  were	  complete,	  the	  beads	  with	  
were	   transferred	   into	   separate	   vials.	   The	   vials	   were	   filled	  with	   ammonium	   hydroxide	  
and	   placed	   in	   55⁰C	  water	   bath	   overnight	   in	   order	   to	   deprotect	   the	   oligos	   and	   cleave	  
them	  from	  the	  CPG	  beads.	  Then	  the	  cooled	  supernatant	  solutions	  was	  dried	   in	  vacuo,	  
then	  re-­‐dissolved	  in	  4-­‐6	  mL	  of	  water	  for	  purification.	  






Figure	  1.	  The	  new	  adenine	  analogue	  hEtThm3c3A	  and	  TBDMS-­‐protected	  hEtThm3c3A	  
	  
(Oligo	   R3	   reverse-­‐phase	   C18	   column,	   trityl	   on),	   starting	   with	   100%	   A,	   using	   a	   linear	  
gradient	   from	  0	   to	  50%	  B	  over	  30	  min	   (A:	  1	  M	  TEAA	  (pH	  7)	   in	  5%	  acetonitrile;	  B:	  1	  M	  
TEAA	   (pH	   7)	   in	   70%	   acetonitrile).	   The	  DMT-­‐protected	   12-­‐mers	   had	   retention	   times	   of	  
about	  17.5	  minutes,	  except	  for	  sequence	  3,	  which	  had	  a	  retention	  time	  of	  24	  min.	  We	  
assumed	   this	   was	   due	   to	   the	   presence	   of	   a	   TBS	   group	   remaining	   on	   the	   modified	  
residue.	  The	  collected	  oligonucleotides	  were	  then	  reduced	  in	  volume	  and	  detritylated	  in	  
80%	  acetic	  acid	  for	  30	  min.	  	  
The	   resulting	   native	   oligonucleotides	  1	   and	  2	   were	   desalted	   (Sephadex	   G-­‐10)	   and	  
lyophilized.	  The	  entire	  product	  containing	  sequence	  3	  was	  divided	   into	  two	  parts.	  One	  
half	   was	   desalted	   and	   lyophilized	   just	   like	   the	   native	   sequences	   (TBDMS	   protecting	  
group	  stayed	  on).	  The	  other	  half	  was	  dissolved	  in	  1	  M	  TBAF	  in	  THF	  solution	  for	  3	  hours	  in	  
order	  to	  remove	  the	  TBDMS	  protecting	  group	  first,	  then	  desalted.	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In	  spite	  of	  the	  promising	  results	  shown	  by	  the	  DNA	  synthesizer	  and	  the	  HPLC,	  MALDI	  
spectra	   showed	   that	   the	  modified	  nucleobase	  might	   not	   have	  been	   incorporated.	   For	  
the	  reasons	  that	  are	  still	  unclear,	  the	  mass	  of	  the	  modified	  sequence	  did	  not	  match	  the	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